Pages
- #59010 (no title)
- #59008 (no title)
- Accessibility Statement
- Blog
- Contact
- Data and Research Tool Repository
- Home Page
- Login
- My Account
- NCS I’m Interested
- NCS I’m Interested DEV
- NCS I’m Interested- Real ID – Thank you
- NCS Incentives
- NCS Landing
- Privacy Policy
- Research Library
- Researcher Portal Registration
- Sitemap
- Terms of Use
- What We Do
- Who We Are
Posts by category
- Category: News
Downloads
FAQs
- What will you do with my data and how is my privacy protected?
- Who can access my data?
- Can I access my data?
- Who can I contact if I have questions during the study?
- Will I be compensated for participating in the study?
- Can I withdraw from the study at any time?
- What are the potential risks of participating?
- When can I start using cannabis after enrolling in the study?
- Can I use other substances or medications during the study?
- How long is the study?
- What will I be required to do if I participate?
- I’m currently using cannabis. Can I enroll in the study?
- Who is eligible to participate in this study?
- What is the purpose of this study?
Tableau Dashboards
- Research Library Dashboard
- AWSExampleDashboard
- CHRI Research Library
- AWS Example Dashboard - caregiver
- AWS Example Dashboard - age
- AWS Example Dashboard - gender
- AWS Example Dashboard - groups
- Poverty Rates
- Lighthouses of Greece
- Steve Spielberg
- Global Temperatures
- Fleetwood Mac
- AWS Example Dashboard
- AWS Example Dashboard - education
Glossary
- Sublingual
- Entourage Effect
- Bioavailability
- CB2 Receptor
- CB1 Receptor
- Anandamide (AEA)
- Full Spectrum
- Broad Spectrum
- Isolate
- THCV (Tetrahydrocannabivarin)
- In vivo
- In vitro
- THC-A
- THC
- Terpene
- Phyto
- Over-saturation
- Neuro-modulation
- MC/MMJ
- Hemp Oil vs. Hemp Seed Oil
- Hemp (Scientific Definition)
- Hemp (Legal Definition)
- Half-Life
- Flavonoid
- Entourage Effect
- Endocannabinoid System (ECS)
- Cannabis
- Cannabinoid
- CBD
Research
- Analyzing cannabinoid-induced abnormal behavior in a zebrafish model
- Cannabinoid Control of Olfactory Processes: The Where Matters
- Drug interactions with cannabinoids
- Sex-specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212-2 depend on mGlu5 receptor signalling
- Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA
- Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
- Synthetic cannabinoids and their impact on neurodevelopmental processes
- Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors
- A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
- Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors
- Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments
- Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial
- In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
- Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use
- Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis
- Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia
- Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease
- Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2
- Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis
- Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome
- Cannabinoids in the Older Person: A Literature Review
- Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2
- Cannabinoid Oil Vaping-Associated Lung Injury and its Radiographic Appearance
- Sexual dimorphic distribution of cannabinoid 1 receptor mRNA in adult C57BL/6J mice
- The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
- A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
- Open Access Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study
- Cannabis use in Adolescence and Risk of Psychosis: Are there Factors that Moderate this Relationship? A Systematic Review and Meta-Analysis
- Rates of Prenatal Cannabis Use Among Pregnant Women Before and During the COVID-19 Pandemic
- Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit
- Cannabis-related Hospitalizations Among Youth in Canada Before and After Cannabis Legalization
- Does how you use matter? The link between mode of use and cannabis-related risk
- Prevalence of cannabis use among individuals with a history of cancer in the United States
- Toxicology of flavoring- and cannabis-containing e-liquids used in electronic delivery systems
- A systematic review of medical students’ and professionals’ attitudes and knowledge regarding medical cannabis
- Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
- Decreasing perceived risk associated with regular cannabis use among older adults in the United States from 2015 to 2019
- Cannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid
- Cannabinoids, Endocannabinoids and Sleep
- Cannabinoids in the Pathophysiology of Skin Inflammation
- Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
- An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry Skin
- Cannabinoids for the treatment of chronic pruritus: A review
- Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
- Cannabinoid Exposure via Lactation in Rats Disrupts Perinatal Programming of the Gamma-Aminobutyric Acid Trajectory and Select Early-Life Behaviors
- The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies
- Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder
- The Antimicrobial Activity of Cannabinoids
- The other side of the leaf: Seizures associated with synthetic cannabinoid use
- Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
- Cannabinoid use among Americans with MS: Current trends and gaps in knowledge
- The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications
- Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department
- Cannabinoids as anticancer therapeutic agents
- Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications
- Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis
- Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review
- 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity
- Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
- Critical Illness Secondary to Synthetic Cannabinoid Ingestion
- Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence
- The (endo)cannabinoid signaling in female reproduction: What are the latest advances?
- The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
- Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
- Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study
- Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells
- Cannabinoid Hyperemesis Syndrome: Definition, Pathophysiology, Clinical Spectrum, Insights into Acute and Long-Term Management
- Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex
- Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
- CrossRef citations to date 0 Altmetric Listen Commentary Challenges of Cannabinoid Delivery: How Can Nanomedicine Help?
- Cannabinoid-sensitive receptors in cardiac physiology and ischaemia
- Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
- Cannabinoid control of neurogenic inflammation
- Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review
- Methods for quantification of cannabinoids: a narrative review.
- Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract
- Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
- Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis
- Patterns of brain function associated with cannabis cue-reactivity in regular cannabis users: a systematic review of fMRI studies
- Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs
- Interventions for cannabis use disorder
- The acute and non-acute effects of cannabis on reward processing: A systematic review
- Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder
- Education, Knowledge, and Practice Characteristics of Cannabis Physicians: A Survey of the Society of Cannabis Clinicians
- Medical cannabis education among healthcare trainees: A scoping review
- Are Sweet Dreams Made of These? Understanding the Relationship Between Sleep and Cannabis Use
- Glucose metabolism links astroglial mitochondria to cannabinoid effects
- Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
- Safety Considerations in Cannabinoid-Based Medicine
- Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
- Characteristics and circumstances of synthetic cannabinoid-related death
- Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms
- Cannabinoids and Cannabinoid Receptors: The Story so Far
- Residual Effects of Cannabis Use on Effort-Based Decision-Making
- Comparing older nonmedical and medical cannabis users: health-related characteristics, cannabis use patterns, and cannabis sources
- Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss
- The longitudinal relationship between cannabis use and hypertension
- Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro
- The Chemistry of Cannabis and Cannabinoids
- Young adult cannabis use disorder treatment admissions declined as past month cannabis use increased in the U.S.: An analysis of states by year, 2008–2017
- Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional studyUse of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study
- Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
- A Proteomic View of Cellular and Molecular Effects of Cannabis
- Adolescent cannabis use, depression and anxiety disorders in the Northern Finland Birth Cohort 1986
- Polish Physicians’ Perspectives on Medical Cannabis Policy and Educational Needs: Results of An Online Survey
- Cannabis use-related working memory deficit mediated by lower left hippocampal volume
- Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis
- Desistance, Self-treatment, or Substitution: Decisions about Cannabis Use During Pregnancy
- Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche
- Bipolar disorder and cannabis use: A bidirectional two-sample Mendelian randomization study
- Ancient psychoactive plants in a global village: The ritual use of cannabis in a self-managed community in Catalonia
- Regulatory status of pesticide residues in cannabis: Implications to medical use in neurological diseases
- Resting state functional connectivity in the default mode network: Relationships between cannabis use, gender, and cognition in adolescents and young adults
- Recreational Cannabis Use Before and After Legalization in Women With Pelvic Pain
- Cannabis use among Norwegian university students: Gender differences, legalization support and use intentions, risk perceptions, and use disorder
- The association between cannabis use disorder and the outcome following primary total hip arthroplasty
- Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities
- Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study
- A Scoping Review of Associations Between Cannabis Use and Anxiety in Adolescents and Young Adults
- Perception and practices regarding cannabis consumption in Karachi, Pakistan: A cross-sectional study
- Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women
- Altered fronto-occipital connectivity during visual selective attention in regular cannabis users
- Prevalence and correlates of non-daily and daily cannabis use among persons 15 years and older in South Africa: results of a national survey in 2017
- The Neurocognitive Effects of Cannabis Across the Lifespan
- 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers
- Modes of cannabis use among Canadian youth in the COMPASS study; using LCA to examine patterns of smoking, vaping, and eating/drinking cannabis
- Chapter Three - Cannabis exposure during adolescence: A uniquely sensitive period for neurobiological effects
- Weeding through the haze: a survey on cannabis use among people living with Parkinson’s disease in the US
- Cytotoxicity, anti-acute leukemia, and antioxidant properties of gold nanoparticles green-synthesized using Cannabis sativa L leaf aqueous extract
- Preliminary assessment of medical cannabis consumption by cancer survivors
- Cognition and Cortical Thickness in Heavy Cannabis Users
- Gender Differences in Medical Cannabis Use: Symptoms Treated, Physician Support for Use, and Prescription Medication Discontinuation
- Neuropsychological and neurophysiological predictors and consequences of cannabis and illicit substance use during neurodevelopment: a systematic review of longitudinal studies
- Methylomic Investigation of Problematic Adolescent Cannabis Use and Its Negative Mental Health Consequences
- Methylomic Investigation of Problematic Adolescent Cannabis Use and Its Negative Mental Health Consequences
- Antifungal and anti-aflatoxigenic properties of organs of Cannabis sativa L.: relation to phenolic content and antioxidant capacities
- UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis
- Are researchers getting the terms used to denote different types of recreational cannabis right?—a user perspective
- A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window
- Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study
- Green Synthesis of Silver Nanoparticles Using Cannabis sativa Extracts and Their Anti-Bacterial Activity
- Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois
- Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network
- Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress
- Cannabis use among early adolescents and transdiagnostic mental health risk factors
- Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles
- In vitro cholinesterase inhibitory action of Cannabis sativa L. Cannabaceae and in silico study of its selected phytocompounds
- Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis
- The Influence of Distressed Coping on the Relationship between Perceived Racial Discrimination and Cannabis Use among Black College Students
- Factors Associated With Cannabis Use During the Reproductive Cycle: A Retrospective Cross-Sectional Study of Women in States With Recreational and Medical Cannabis Legalization
- The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients
- Differential Cognitive Performance in Females and Males with Regular Cannabis Use
- Differences between cancer patients and others who use medicinal Cannabis
- Cultural race-related stress and cannabis use among incarcerated African American men.
- The impact of cannabis use on male sexual function: A 10-year, single-center experience
- Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study
- Nonmedical Cannabis Use: Patterns and Correlates of Use, Exposure, and Harm, and Cancer Risk
- Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process
- Cognitive Development and Cannabis Use in Adolescents
- The use of medical cannabis in pediatric palliative care: a case series
- The Anticipated Effects of Cannabis Scale (AECS): Initial development and validation of an affect- and valence-based expectancy measure.
- Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists
- Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians
- Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls
- Willingness to Use Cannabis for Gynecological Conditions: A National Survey
- Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial
- Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models
- Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study
- Use of Cannabis for Harm Reduction Among People at High Risk for Overdose in Vancouver, Canada (2016–2018)
- Topical cannabis-based medicines – A novel adjuvant treatment for venous leg ulcers: An open-label trial
- Beneficial Effects of Cannabis on Blood–Brain Barrier Function in Human Immunodeficiency Virus
- Association of Cannabis Use With Self-harm and Mortality Risk Among Youths With Mood Disorders
- Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
- Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood
- Cannabis use disorder treatment use and perceived treatment need in the United States: Time trends and age differences between 2002 and 2019
- Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
- Effect of the Distillation Time on the Chemical Composition, Antioxidant Potential and Antimicrobial Activity of Essential Oils from Different Cannabis sativa L. Cultivars
- Correlates of patterns of cannabis use, abuse and dependence: evidence from two national surveys in Ireland
- Intelligence quotient decline following frequent or dependent cannabis use in youth: a systematic review and meta-analysis of longitudinal studies
- Anesthesia for Patients Who Self-Report Cannabis (Marijuana) Use Before Esophagogastroduodenoscopy: A Retrospective Review
- Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis
- Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study
- Cannabis use, sedentary behavior, and physical activity in a nationally representative sample of US adults
- Cannabis Use and Oral Health in a National Cohort of Adults
- Cannabis use frequency, route of administration, and co-use with alcohol among older adults in Washington state
- Acute Effects of Cannabis on Symptoms of Obsessive-Compulsive Disorder
- Efficacy and safety of paediatric medicinal cannabis use: A scoping review
- The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health
- Cannabis use and mental health among young sexual and gender minority men: A qualitative study
- Perceived risk of harm from monthly cannabis use among US adolescents: National Survey on drug Use and Health, 2017
- Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes
- Antioxidant and antimicrobial activity of two standardized extracts from a new Chinese accession of non-psychotropic Cannabis sativa L.
- Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption
- In vivo and in vitro anti-inflammatory activity evaluation of Lebanese Cannabis sativa L. ssp. indica (Lam.)
- The association of cannabis use with quality of life and psychosocial functioning in psychosis
- Emotion Dysregulation Moderates the Association Between Stress and Problematic Cannabis Use
- Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease
- Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 2019
- Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
- Recent Trends in Cannabis Use in Older Americans
- Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019–2020 National Health and Resilience in Veterans Study
- Green Synthesis, Characterization, and Antibacterial Properties of Silver Nanoparticles Obtained by Using Diverse Varieties of Cannabis sativa Leaf Extracts
- Perioperative Cannabis as a Potential Solution for Reducing Opioid and Benzodiazepine Dependence
- Where, When and With Whom: Cannabis Use, Settings and Self-Regulation Rules
- Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis
- The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System
- Social Anxiety, Cannabis Use Motives, and Social Context’s Impact on Willingness to Use Cannabis
- Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
- Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
- Cannabis Use and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study
- Sex and dependence related neuroanatomical differences in regular cannabis users: findings from the ENIGMA Addiction Working Group
- Medicinal cannabis use in palliative care
- Medicinal applications of cannabis/cannabinoids
- ‘I take it to relax… and chill’: perspectives on cannabis use from marginalized Nigerian young adults
- Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring
- Relationship between cannabis use and psychotic experiences in college students
- In vitro antioxidant and antimicrobial activity of Cannabis sativa L. cv ʻFutura 75ʼ essential oil
- A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders
- Frequent teenage cannabis use: Prevalence across adolescence and associations with young adult psychopathology and functional well-being in an urban cohort
- Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
- Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis
- Intersectional analysis of cannabis use, stigma and health among marginalized Nigerian women
- Effect of roasting on antioxidative properties, polyphenol profile and fatty acids composition of hemp (Cannabis sativa L.) seeds
- Age-Related Differences in Cannabis Product Use
- Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development
- No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms.
- Effects of cannabis on visual function and self-perceived visual quality
- Different Cannabis sativa Extraction Methods Result in Different Biological Activities against a Colon Cancer Cell Line and Healthy Colon Cells
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms
- Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
- Knowledge and Practice of Harm Reduction Strategies Among People Who Report Frequent Cannabis Use
- Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys
- The Use of Cannabis for Medical Purposes in the Arab World
- High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy
- Cannabis, Vaping, and Respiratory Symptoms in a Probability Sample of U.S. Youth
- The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis
- Cannabis use motivations: a study of young adults in Nigeria
- Cannabis vaping among adults in the United States: Prevalence, trends, and association with high-risk behaviors and adverse respiratory conditions
- Adverse effects of heavy cannabis use: even plants can harm the brain
- Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study
- Attitudes and knowledge about medical cannabis among Israeli and American nursing students
- Correlates of continued cannabis use during pregnancy
- Cannabis-Related Perceptions as Mediators of the Association Between Trait Impulsivity and Cannabis Outcomes
- Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
- Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
- Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
- Cannabis use disorder and increased risk of arrhythmia-related hospitalization in young adults
- Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
- Evidence Lacking for Cannabis Users Slacking: A Longitudinal Analysis of Escalating Cannabis Use and Motivation among Adolescents
- Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study
- Cannabis Consumption, Purchasing and Sources among Young Canadians: The Cannabis Purchase and Consumption Tool (CPCT)
- Association of Cannabis Retailer Proximity and Density With Cannabis Use Among Pregnant Women in Northern California After Legalization of Cannabis for Recreational Use
- The sexualised use of cannabis among young sexual minority men: “I’m actually enjoying this for the first time”
- Cannabis use disorder and perioperative outcomes in vascular surgery
- The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
- Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review
- Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
- Longitudinal associations of cannabis, depression, and anxiety in heterosexual and LGB adolescents.
- Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain
- Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials
- Cannabis roots: Pharmacological and toxicological studies in mice
- Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
- Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages
- Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence
- The Effects of Cannabis on Female Reproductive Health Across the Life Course
- Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations
- Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank
- Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State
- Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients
- Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study
- Young-adult compared to adolescent onset of regular cannabis use: A 20-year prospective cohort study of later consequences
- Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
- Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis
- The effect of attitudes, subjective norms and stigma on health-care providers' intention to recommend medicinal cannabis to patients
- Changes in cannabis use modes among Canadian youth across recreational cannabis legalization: Data from the COMPASS prospective cohort study
- Mechanisms of cannabis impairment: Implications for modeling driving performance
- Use of Medical Cannabis to Treat Traumatic Brain Injury
- GC–MS based metabolomic approach to understand nutraceutical potential of Cannabis seeds from two different environments
- The Effects of Cannabis sativa L. Extract on Oxidative Stress Markers In Vivo
- Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial
- Increased Likelihood of Falling in Older Cannabis Users vs. Non-Users
- Emergency Department Pediatric Visits in Alberta for Cannabis After Legalization
- Understanding cancer survivors’ reasons to medicate with cannabis: A qualitative study based on the theory of planned behavior
- The relationship between cannabis use and IVF outcome—a cohort study
- The Potential Use of Cannabis in Tissue Fibrosis
- Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
- The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
- Family Climate and Intention to Use Cannabis as Predictors of Cannabis Use and Cannabis-Related Problems among Young University Students
- Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis
- Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV
- Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath
- Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial
- Cannabis Glandular Trichomes: A Cellular Metabolite Factory
- The Effects of Cannabis on Female Reproductive Health Across the Life Course
- Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review
- Older Cannabis Users Are Not All Alike: Lifespan Cannabis Use Patterns
- Cannabis Abuse and Perioperative Complications Following Inpatient Spine Surgery in the United States
- Neuropsychological performance in young adults with cannabis use disorder
- Effect of preoperative cannabis use on perioperative outcomes: a retrospective cohort study
- Cannabis use and psychosocial functioning: evidence from prospective longitudinal studies
- Cannabis Affects Cerebellar Volume and Sleep Differently in Men and Women
- Cannabis and Migraine: It’s Complicated
- Motivational Interviewing for Cannabis Use Disorders: A Systematic Review and Meta-Analysis
- Use of Cannabis for Self-Management of Chronic Pelvic Pain
- Cannabis use among military veterans: A great deal to gain or lose?
- Alcohol use, cannabis use, and psychopathology symptoms among college students before and after COVID-19
- Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs
- Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study
- Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
- Toward medical cannabis education in Israel
- Associations between adolescent cannabis use and young-adult functioning in three longitudinal twin studies
- Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia
- Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample
- Cannabis and Autoimmunity: Possible Mechanisms of Action
- Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
- Flavonoids in Cannabis sativa: Biosynthesis, Bioactivities, and Biotechnology
- Beyond the high: Mapping patterns of use and motives for use of cannabis as medicine
- The relationship between cannabis and schizophrenia: a genetically informed perspective
- Availability of medical cannabis dispensaries and cannabis abuse/dependence-related hospitalizations in California
- The Current and Potential Application of Medicinal Cannabis Products in Dentistry
- Cannabis Use in Older Adults: A Perspective
- Cannabis Sativa L.: a comprehensive review on the analytical methodologies for cannabinoids and terpenes characterization
- A Literature Review of Cannabis and Myocardial Infarction—What Clinicians May Not Be Aware Of
- The Cannabis Effect on Crime: Time-Series Analysis of Crime in Colorado and Washington State
- Challenges for Clinical Cannabis and Cannabinoid Research in the United States
- A review investigating the relationship between cannabis use and adolescent cognitive functioning
- Cannabis Use and Car Crashes: A Review
- Cannabis in the management of PTSD: a systematic review
- The Link between Cannabis Use, Immune System, and Viral Infections
- Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping
- Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws
- Consumer perceptions of ‘legal’ and ‘illegal’ cannabis in US states with legal cannabis sales
- Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies
- Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
- Medical cannabis treatment for chronic pain: Outcomes and prediction of response
- Chemical composition and antioxidant potential of Cannabis sativa L. roots
- Peak-experience and the entheogenic use of cannabis in world religions
- CANNUSE, a database of traditional Cannabis uses—an opportunity for new research
- Quarterly trends in past-month cannabis use in the United States, 2015-2019
- The association of type of cannabis product used and frequency of use with problematic cannabis use in a sample of young adult cannabis users
- Cannabis Policy Changes and Adolescent Cannabis Use: Evidence from Europe
- Cannabis and Inflammatory Mediators
- Cannabis use disorder and the lungs
- Association of Cannabis Use During Adolescence With Neurodevelopment
- Reasons for cannabis use during pregnancy and lactation: a qualitative study
- Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview
- Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics
- Physicians’ experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review
- Cannabis and Lung Health: Does the Bad Outweigh the Good?
- A primer on medicinal cannabis safety and potential adverse effects
- When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services
- Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA
- Analgesic Potential of Terpenes Derived from Cannabis sativa
- Associations of Suicidality Trends With Cannabis Use as a Function of Sex and Depression Status
- Cannabis sativa research trends, challenges, and new-age perspectives
- Trends in youth cannabis use across cannabis legalization: Data from the COMPASS prospective cohort study
- Analysis of State Cannabis Laws and Dispensary Staff Recommendations to Adults Purchasing Medical Cannabis
- Adverse Effects of Recreational and Medical Cannabis
- Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada
- Down and High: Reflections Regarding Depression and Cannabis
- Sociodemographic Characteristics Associated With and Prevalence and Frequency of Cannabis Use Among Adults in the US
- Cannabis: An Emerging Treatment for Common Symptoms in Older Adults
- Cannabis Policy in the United States: Implications for Public Health
- Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain
- The antimicrobial effect behind Cannabis sativa
- Exploring New Use of Cannabis among Older Adults
- Cannabis and driving ability
- Medical cannabis and driving
- Cannabis Marketing and Problematic Cannabis Use Among Adolescents
- Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status
- The why behind the high: determinants of neurocognition during acute cannabis exposure
- Trends over time in adult cannabis use: A review of recent findings
- Processing and extraction methods of medicinal cannabis: a narrative review
- Joint perceptions of the risk and availability of Cannabis in the United States, 2002-2018
- A Comprehensive Review of Cannabis Potency in the United States in the Last Decade
- Cannabis and Driving
- Traditional uses of Cannabis: An analysis of the CANNUSE database
- Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
- Cannabis use and cannabis use disorder
- Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders
- Assessing the neuroprotective benefits of Cannabis sativa in epilepsy management
- Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
- Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug–Drug Interactions Between Immunosuppressants and Cannabis-Derived Products
- The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer
- Cannabis use in Crohn’s disease: a systematic review and meta-analysis of randomized controlled trials (RCTs)
- CBD for pets: navigating quality assurance, safety standards, and marketing strategies
- The cannabinoid CB2 receptor mediates the analgesic effects of Cannabis sativa extract in a rat model of neuropathic pain
- Divergence in cannabis and alcohol use disorder prevalence trends from 2002 to 2019
- The Effect of Cannabis Consumption During Lactation on the Macronutrient Concentrations in Breast Milk
- Cannabis use among individuals with depression symptoms: differences among military-connected and civilian clients
- Brain Function Outcomes of Recent and Lifetime Cannabis Use
- Historical change in associations between perceived risk, disapproval, and use of cannabis among young adults ages 19–30, 2011–2022
- Associations between adult cannabis use and chronic health conditions in a nationally representative sample of the United States
- Multi-Modal Cannabis Use Among U.S. Young Adults: Findings from the 2022 and 2023 BRFSS in 23 States
- Low doses of cannabis extract ameliorate non-motor symptoms of Parkinson’s disease patients: a case series
- Drug interactions in a sample of inpatients diagnosed with cannabis use disorder
- The Intersection of Rurality, Unmet Treatment Need, and Cannabis Use for Adults with Chronic Pain
- Inpatient outcomes of rheumatoid arthritis in hospitalized patients using cannabis: data from the National Inpatient Sample
- Cannabis Consumption Among Adults Aged 55–65 in Canada, 2018–2021
- Evaluation of cannabis-derived anti-inflammatory and analgesic treatment in animals and identification of cannabinoid-based effective inhibition of prostaglandin through computational studies
- A National Survey Study of Cannabis Use During Menopause: Identifying Variables Associated With Recreational, Medical, and Hybrid Use
- Cannabis expectancies and associations with cannabis use and health functioning among adults with chronic pain
- The acute effects of vaporized cannabis on drivers’ hazard perception and risk-taking behaviors in medicinal patients: A within-subjects experiment
- Unmet Healthcare Needs and Medical Cannabis Use Among Sexual and Gender Minoritized Adults in a High-Stigma Environment
- Haven't I waited long enough? The role of wait times and subjective impairment in cannabis-related driving behavior
- The State of the Evidence for Medical Cannabis as a Treatment for Pain-related Sleep Impairments: Integrating Social Determinants of Health into Research Design and Policy
- International perspectives on physician knowledge, attitudes, and practices related to medical cannabis
- Young Adult Medical Cannabis Patients in Florida: Gender Differences in Characteristics of use, Experiences at Dispensaries, and Association With Health-Related Problems
- An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study
- Correlates of Using Medically-Authorized Cannabis in a Large Cohort of People Living with HIV Who Use Cannabis
- Efficacy and Safety of Transdermal Medical Cannabis (THC:CBD:CBN formula) to Treat Painful Diabetic Peripheral Neuropathy of Lower Extremities
- Reducing medical cannabis use risk among Veterans: A descriptive study
- Cumulative Social Disadvantage and Medicinal Cannabis Use Among Younger Adults in Rural Communities: A Mixed Methods Approach
- A qualitative exploration of the management of impaired driving in medicinal cannabis patients
- UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain
- A Case Report of Treatment-Resistant Agitation in Dementia With Lewy Bodies: Medical Marijuana as an Alternative to Antipsychotics
- Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019
- A survey of patients with cancer and oncology health-care professionals about cannabis use during treatment
- Potential Risks from Cannabis-Infused Beverages: A Critical Review
- Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport
- In Vitro and In Vivo Anti-Inflammatory and Antidepressant-like Effects of Cannabis sativa L. Extracts
- Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients
- Patients’ Health‑Related Quality of Life and Use of Medicinal Cannabis: A Cross‑Sectional Survey Study
- Cannabis consumption and risk of asthma: a systematic review and meta-analysis
- The comparative effectiveness of medicinal cannabis for chronic pain versus prescription medication treatment
- Cancer risk and legalisation of access to cannabis in the USA: overview of the evidence
- Drug dependence epidemiology in palliative care medicinal cannabis trials
- The acute effects of vaporized cannabis on drivers’ hazard perception and risk-taking behaviors in medicinal patients: A within-subjects experiment
- In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities
- Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
- Cumulative Social Disadvantage and Medicinal Cannabis Use Among Younger Adults in Rural Communities: A Mixed Methods Approach
- Understanding Older Adults’ Experiences with Cannabis for Medicinal Purposes: A Mixed Methods Study
- Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach
- Medicinal cannabis tea contains variable doses of cannabinoids and no terpenes
- Targeting mitochondrial dysfunction in atopic dermatitis with trilinolein: A triacylglycerol from the medicinal plant Cannabis fructus
- Medicinal Cannabis and the Intestinal Microbiome
- Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization
- Association of Cannabis Use Disorder With Hospitalizations for Pulmonary Embolism and Subsequent in‐Hospital Mortality in Young Adults: A Contemporary Nationwide Analysis
- Cannabis use, sleep and mood disturbances among persons with epilepsy – A clinical and polysomnography study from a Canadian tertiary care epilepsy center
- Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers
- Emerging trends in cannabis administration for women with chronic pain
- Cannabinoids for Inflammatory Bowel Disease: A Scoping Review
- Incident psychotic experiences following self-reported use of high-potency cannabis: Results from a longitudinal cohort study
- Cannabis Use Among Cancer Patients During Active Treatment: Findings From a Study at an NCI-Designated Cancer Center
- Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients
- Executive functions and behavioral economic demand for cannabis among young adults: Indirect associations with cannabis consumption and cannabis use disorder
- The Therapeutic Potential of Cannabidiol in the Management of Temporomandibular Disorders and Orofacial Pain
- Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review
- The role of cannabis on total hip and knee surgeries outcomes: a systematic review and meta-analysis
- Clinical effectiveness of medical marijuana in patients with amyotrophic lateral sclerosis
- Associations between Cannabis Consumption Methods and Cannabis Risk Perception
- The impact of cannabis use proximal to sleep and cannabinoid metabolites on sleep architecture
- Where Do Adults in the United States Obtain Cannabis? A Nationally Representative Study Examining the Relationships Between Sociodemographic Factors, Cannabis Use Characteristics and Sources of Cannabis
- Cannabis Use and Trajectories of Depression and Stress Across the Prenatal Period
- Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year
- Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013
- Cannabis Dependence is Associated with Reduced Hippocampal Subregion Volumes Independently of Sex: Findings from an ENIGMA Addiction Working Group Multi-Country Study
- Adult use cannabis legalization and cannabis use disorder treatment in California, 2010–2021
- The effects of cannabis use on major adverse cardiovascular outcomes, mortality, cost of hospitalization, and cardiac arrhythmias: A Retrospective analysis using the national inpatient sample
- Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry
- Cannabis Perceptions and Patterns of Use Among Older Adult Cancer Survivors
- Does cannabis substitute or complement alcohol after recreational cannabis legalization in the Washington State? A three-level mixed-effects modeling
- Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled Study
- An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study
- Factors associated with the use of cannabis for self-medication by adults: data from the French TEMPO cohort study
- The association of medical cannabis use with quality of life in Illinois’ opioid alternative pilot program
- Perceived Risk of Medical Cannabis and Prescribed Cannabinoids for Chronic Pain: A Cross-Sectional Study Among Quebec Clinicians
- Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis
- Discussions of Cannabis Over Patient Portal Secure Messaging: Content Analysis
- Correlates of Using Medically-Authorized Cannabis in a Large Cohort of People Living with HIV Who Use Cannabis
- Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study
- Motherhood and medicinal cannabis
- Pre-Post Cannabis Legalization for Adult Use: A Trend Study of Two Cohorts of Young Adult Cannabis Users in Los Angeles
- Identification of the TRPA1 cannabinoid-binding site
- Cannabis Consumption Among Adults Aged 55–65 in Canada, 2018–2021
- Association between cannabis potency and mental health in adolescence
- Association between cannabis use and physical activity in the United States based on legalization and health status
- Social Norms for Cannabis Use After Nonmedical Legalization in Canada
- Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study
- Evidence for the use of cannabis-based medicines in osteoarthritis: a scoping review
- Perceptions of Cannabis Use and Its Benefits and Risks Among Breastfeeding Mothers
- Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017–2021
- Light Cannabis Use and the Adolescent Brain: An 8-years Longitudinal Assessment of Mental Health, Cognition, and Reward Processing
- The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review
- Medical Marijuana for Pain Management in Hospice Care as a Complementary Approach to Scheduled Opioids: A Single Arm Study
- Cannabis expectancies and associations with cannabis use and health functioning among adults with chronic pain
- Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study
- Efficacy and Safety of Transdermal Medical Cannabis (THC:CBD:CBN formula) to Treat Painful Diabetic Peripheral Neuropathy of Lower Extremities
- Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review
- Real world clinical outcomes of treatment of cannabis-induced psychosis and prevalence of cannabis-related primary psychosis: a retrospective study
- UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain
- A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
- Medicinal cannabis extracts are neuroprotective against Aβ1–42-mediated toxicity in vitro
- Cannabis Use Reported by Patients Receiving Primary Care in a Large Health System
- Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry
- Medical marijuana in the treatment of cancer-associated symptoms
- A Statewide Examination of Medical Cannabis Purchasing Patterns in Arkansas Over the Three Years Immediately Following Legalization
- Cannabinoids Used for Medical Purposes in Children and Adolescents A Systematic Review and Meta-Analysis
- A National Survey Study of Cannabis Use During Menopause: Identifying Variables Associated With Recreational, Medical, and Hybrid Use
- The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA: Does it depend on prior history of cannabis use?
- Unmet Healthcare Needs and Medical Cannabis Use Among Sexual and Gender Minoritized Adults in a High-Stigma Environment
- Comparison Between Smoked Tobacco and Medical Cannabis Cigarettes Concerning Particulate Matter
- The effect of non-medical cannabis retailer proximity on use of mental health services for psychotic disorders in Ontario, Canada
- Highs and Lows: A Mixed-Methods Analysis of the Impact of Adult Use Legalization on Medical Cannabis Patients
- Planting the seeds for success: A qualitative study exploring primary healthcare providers’ perceptions about medical cannabis
- UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment
- Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
- UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease
- Licensed Medical Cannabis Use in Gilles de la Tourette Syndrome: A Retrospective Long-term Follow-Up
- UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder
- Clinical outcome analysis of patients with multiple sclerosis – Analysis from the UK Medical Cannabis Registry
- Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study
- Impact of medical and recreational cannabis laws on inpatient visits for asthma
- Characteristics for Medical Cannabis Treatment Adherence among Autistic Children and Their Families: A Mixed-Methods Analysis
- Longitudinal Associations Between Cannabis Use and Cognitive Impairment in a Clinical Sample of Middle-Aged Adults Using Cannabis for Medical Symptoms
- Effects of medical cannabis use on physical and psychiatric symptoms across the day among older adults
- How have cannabis use and related indicators changed since legalization of cannabis for non-medical purposes? Results of the Canadian Cannabis Survey 2018–2022
- Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient
- Impact of Medical Cannabis on Recovery from Playing-Related Musculoskeletal Disorders in Musicians: An Observational Cohort Study
- Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada
- Effects of Medical Cannabis Certification on Hospital Use by Individuals with Sickle Cell Disease
- Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada
- Is a Low Dosage of Medical Cannabis Effective for Treating Pain Related to Fibromyalgia? A Pilot Study and Systematic Review
- Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study
- Perceptions and engagement of patients with chronic conditions on the use of medical cannabis: a scoping review
- Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization
- Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors
- Medical cannabis use in young adults with cancer: a self-reported survey study
- Medical Cannabis Dosing Trajectories of Patients: Evidence From Sales Data
- Cannabis Use and Head and Neck Cancer
- Use of Cannabis-Based Medical Products for Pediatric Health Conditions: A Systematic Review of the Recent Literature
- Systematic Review and Meta-Analysis: Medical and Recreational Cannabis Legalization and Cannabis Use Among Youth in the United States
- Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive Processes
- Medical cannabis: From research breakthroughs to shifting public perceptions and ensuring safe use
- Medical cannabis use in oncology and associated outcomes: A scoping review
- Changes in prenatal cannabis-related diagnosed disorders after the Cannabis Act and the COVID-19 pandemic in Quebec, Canada
- Predictors for cannabis cessation during pregnancy: a 10-year cohort study
- Cannabinoid hyperemesis syndrome: prevalence and management in an era of cannabis legalization
- Trajectory modeling of cannabis use over 30 years identifies five unique longitudinal patterns
- Effect of recreational cannabis use on bone mineral density: a systematic review
- Effects of Cannabis on Glutamatergic Neurotransmission: The Interplay between Cannabinoids and Glutamate
- Cannabis sativa in veterinary medicine: Foundations and therapeutic applications
- Effects of cannabis use on the heart
- Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment
- Cannabis Sativa targets mediobasal hypothalamic neurons to stimulate appetite
- Adverse Impact of Cannabis on Human Health
- Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
- Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review
- Therapeutic potential of CBD in Autism Spectrum Disorder
- Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm
- The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review
- “I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD
- Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review
- Neurodevelopmental Effects of Cannabis Use in Adolescents and Emerging Adults with ADHD: A Systematic Review
- ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders
- Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial
- Cannabis use in Attention – Deficit/Hyperactivity Disorder (ADHD): A scoping review
- Comparative Pharmacokinetic Assessment of Innovative Sublingual, Rectal and Vaporizer Cannabis Products Versus Approved Cannabis Products in Healthy Volunteers
- Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC
- Cannabis use preferences in women with myofascial pelvic pain: A cross-sectional study
- Cannabinoids for skin diseases and hair regrowth
- Positive Effect of Cannabis sativa L. Herb Extracts on Skin Cells and Assessment of Cannabinoid-Based Hydrogels Properties
- Quantification of Cannabis in Infused Consumer Products and Their Residues on Skin
- Cannabis-related allergies: An international overview and consensus recommendations
- Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury
- Cannabis significantly alters DNA methylation of the human ovarian follicle in a concentration-dependent manner
- Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand
- Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey
- Effect of cannabidiol (CBD), a cannabis plant derivative, against Candida albicans growth and biofilm formation
- Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017
- Cannabis Use During Early Pregnancy Following Recreational Cannabis Legalization
- Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study
- Cannabis and Pregnancy
- Sleep Quality Moderates the Relation between Depression Symptoms and Problematic Cannabis Use among Medical Cannabis Users
- Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor
- Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: a double-blind, placebo-controlled, randomized, crossover study
- The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects
- Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership
- Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults A Randomized Clinical Trial
- UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia
- Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing
- Longitudinal associations between insomnia, cannabis use and stress among US veterans
- The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review
- Use of Cannabidiol in the Management of Insomnia: A Systematic Review
- Cannabis-based products for pediatric epilepsy: A systematic review
- Obsessive-Compulsive Symptoms and Cannabis Misuse: The Explanatory Role of Cannabis Use Motives
- Symptoms of obsessive-compulsive disorder predict cannabis misuse
- The Impact of Marijuana Use on Postoperative Outcomes in Abdominal-based Free Flap Breast Reconstruction
- Item response theory analysis of benefits and harms of cannabis use in cancer survivors
- Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
- Medicinal cannabis oil improves anxiety-like and depressive-like behaviors in CCS mice via the BDNF/TRPC6 signaling pathway
- Exploring the interplay between cannabinoids and thymic functions
- The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review
- Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal Study
- A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats
- Drug Interactions in People on Cannabidiol: Is There Cause for Concern?
- Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
- Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients
- Cannabis use and patient-reported outcomes among patients at a comprehensive cancer center
- Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey
- Mental and Physical Health-Related Cannabis Motives Mediate the Relationship between Childhood Trauma and Problematic Cannabis Use over Time among Emerging Adult Cannabis Users
- Cannabis-Induced Gastrointestinal Tract Symptoms in the Adult Population: A Systematic Review
- Evaluating the Current Evidence for the Efficacy of Cannabis in Symptom Management of Endometriosis-Associated Pain
- Cannabis oil extracts for chronic pain: what else can be learned from another structured prospective cohort?
- The Effect of Oil-Based Cannabis Extracts on Metabolic Parameters and Microbiota Composition of Mice Fed a Standard and a High-Fat Diet
- Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM
- Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
- Medical cannabis increases appetite but not body weight in patients with inflammatory bowel diseases
- Evaluation of potential drug–drug interactions with medical cannabis
- Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder
- Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer
- A Retrospective Cohort Study That Examined the Impact of Cannabis Consumption on Long-Term Kidney Outcomes
- A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids
- Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study
- Limited psychological and social effects of lifetime cannabis use frequency: Evidence from a 30-year community study of 4,078 twins
- Daily associations with cannabis use and sleep quality in anxious cannabis users
- Edible cannabis for chronic low back pain: associations with pain, mood, and intoxication
- Comparing Cannabis Use for Pain to Use for Other Reasons in Primary Care Patients
- Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials
- Daily diary study of associations between alcohol, cannabis, co-use and sleep quality in individuals with intentions to use cannabis to cope with anxiety
- Use of cannabis for mental health in the Canadian territories: a cross-sectional study
- Cannabis and Public Health: A Study Assessing Regular Cannabis Users Through Health Indicators
- Harnessing Cannabis sativa Oil for Enhanced Skin Wound Healing: The Role of Reactive Oxygen Species Regulation
- Cannabis Use in Pregnancy and Neonatal Outcomes: A Systematic Review and Meta-Analysis
- Association of Cannabis Use Reduction With Improved Functional Outcomes: An Exploratory Aggregated Analysis From Seven Cannabis Use Disorder Treatment Trials to Extract Data-Driven Cannabis Reduction Metrics
- Acute Effects of Cannabis Inhalation on Arterial Stiffness, Vascular Endothelial Function, and Cardiac Function
- Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients
- Serum Markers of Bone Turnover Following Controlled Administration of Two Medical Cannabis Products in Healthy Adults
- Review of the Use of Medicinal Cannabis Products in Palliative Care
- Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022
- A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance
- Medical cannabis and its efficacy/effectiveness on the management of osteoarthritis pain and function
- The Effects of Stigma: Older Persons and Medicinal Cannabis
- Prenatal Cannabis Use and Maternal Pregnancy Outcomes
- Bidirectional Effect of Long-Term Δ9-Tetrahydrocannabinol Treatment on mTOR Activity and Metabolome
- Buds and Bugs: A Fascinating Tale of Gut Microbiota and Cannabis in the Fight against Cancer
- Nutrition, endocannabinoids, and the use of cannabis: An overview for the nutrition clinician
- Cannabis exposure during pregnancy and perinatal outcomes: A cohort study
- The Role of Cannabis and The Endocannabinoid System in Sleep Regulation and Cognition: A Review of Human and Animal Studies
- The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects
- Prenatal Exposure to Cannabis: Effects on Childhood Obesity and Cardiometabolic Health
- IgE-Mediated Cannabis Allergy and Cross-Reactivity Syndromes: A Roadmap for Correct Diagnosis and Management
- Cannabis and anhedonia: A systematic review
- Cannabis-infused foods: Phytonutrients, health, and safe product innovations
- Cannabis and Cannabinoids in the Perioperative Period
- Cannabinoids in treatment-resistant epilepsy: A review
- Associations Between Prenatal Cannabis Exposure and Childhood Outcomes Results From the ABCD Study
- Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain
- Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics
- Cannabis Use and Earlier Onset of Psychosis A Systematic Meta-analysis
- Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)
- Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
- Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes
- The therapeutic potential of cannabinoids for movement disorders
- A large-scale genome-wide association study meta-analysis of cannabis use disorder
- Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada
- Self-reported Daily, Weekly, and Monthly Cannabis Use Among Women Before and During Pregnancy
- A Multicenter Dose-escalation Study of the Analgesic and Adverse Effects of an Oral Cannabis Extract (Cannador) for Postoperative Pain Management
- Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial
- Effect of cannabis usage on the oral environment: a review
- A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
- Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
- Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
- Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
- What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review
- Medical Cannabis in Asthmatic Patients
- Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohn's Disease
- Cannabis and Male Fertility: A Systematic Review
- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- Treatment of Cannabis Use Disorders: A Review of the Literature
- Lack of Analgesia by Oral Standardized Cannabis Extract on Acute Inflammatory Pain and Hyperalgesia in Volunteers
- Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
- Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis
- Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
- Evaluating the public health impacts of legalizing recreational cannabis use in the United States
- Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
- Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life
- Systematic review of systematic reviews for medical cannabinoids
- Association of Cannabis Use With Cardiovascular Outcomes Among US Adults
- Cannabidiol and Neurodevelopmental Disorders in Children
- Cannabis and synaptic reprogramming of the developing brain
- Use of Cannabis in Fetal Alcohol Spectrum Disorder
- Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats
- The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models
- Medical Marijuana Review of the Science and Implications for Developmental-Behavioral Pediatric Practice
- Genetic basis of cannabis use: a systematic review
- Cannabis use and the sperm epigenome: a budding concern?
- Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin
- Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review
- Potential of cannabinoids as treatments for autism spectrum disorders
- Prenatal Cannabis Use and Offspring Autism-Related Behaviors: Examining Maternal Stress as a Moderator in a Black American Cohort
- Examining the association between prenatal cannabis exposure and child autism traits: A multi-cohort investigation in the environmental influences on child health outcome program
- Cannabinoid treatment for the symptoms of autism spectrum disorder
- Effects of Medical Cannabis Treatment for Autistic Children on Anxiety and Restricted and Repetitive Behaviors and Interests: An Open-Label Study
- A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment
- Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review
- Autism and associated disorders: cannabis as a potential therapy
- Cannabis for the Treatment of Epilepsy: an Update
- Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
- Evidence for the Risks and Consequences of Adolescent Cannabis Exposure
- Role of cannabis in cardiovascular disorders
- Medical Cannabinoids in Children and Adolescents: A Systematic Review
- Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
- An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis
- Adverse effects of medical cannabinoids: a systematic review
- The medicinal use of cannabis in the UK: results of a nationwide survey
- Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?
- Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada – A Qualitative Study
- Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study
- Why Use Cannabis? Examining Motives for Cannabis Use in Individuals with Anxiety Disorders
- CBD treatment following early life seizures alters orbitofrontal-striatal signaling during adulthood
- Selective alterations of endocannabinoid system genes expression in obsessive compulsive disorder
- Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status
- A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies
- Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis
- Cannabis and Anxiety: A Critical Review
- Cannabis use and related clinical variables in patients with obsessive-compulsive disorder
- Patterns of cannabis use among individuals with obsessive-compulsive disorder: Results from an internet survey
- Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate–Induced Dermatitis Model in Mice
- The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders
- Cannabinoids and Their Receptors in Skin Diseases
- Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases—A Synthetic Review
- Topical Use of Cannabis sativa L. Biochemicals
- Cannabinoids for the Treatment of Dermatologic Conditions
- Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases
- Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
- The Skin and Natural Cannabinoids–Topical and Transdermal Applications
- Exploring the Diagnosis and Profile of Cannabis Allergy
- Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
- Cannabinoids in dermatology: a scoping review
- Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
- The Risks and Benefits of Cannabis in the Dermatology Clinic
- Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States
- A Survey of Topical Cannabis Use in Canada
- Cannabis‐based medicines for chronic neuropathic pain in adults
- The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications
- What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
- Association of cannabis potency with mental ill health and addiction: a systematic review
- Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review
- Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis A Systematic Review and Meta-analysis
- Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
- The Anti-Inflammatory Properties of Terpenoids from Cannabis
- The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review
- Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use
- Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management – An overview of systematic reviews
- Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L)
- Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws
- Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
- The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis
- Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study
- Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users
- The intersection between cannabis and cancer in the United States
- Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample
- Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy: Depression is a major confounding factor
- Cannabis Smoking and Periodontal Disease Among Young Adults
- Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method
- Cannabis in medicine: a national educational needs assessment among Canadian physicians
- Acute and subacute bronchial effects of oral cannabinoids
- Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association
- Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization
- An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use
- The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
- Medical Cannabis for the Treatment of Fibromyalgia
- Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
- Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm
- Cannabis use and mental health in young people: cohort study
- Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients
- Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis
- A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers
- Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
- Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly
- Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
- A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
- Medical Cannabis for Older Patients
- The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms
- Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination
- Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis
- Medicinal versus recreational cannabis use among returning veterans.
- A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
- Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients
- The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
- Medicinal Cannabis: A Survey Among Health Care Providers in Washington State
- Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users
- The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
- Medical cannabis and mental health: A guided systematic review
- Medical Cannabis for Neuropathic Pain
- Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
- Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease An Open-Label Observational Study
- ‘The wild west of medicine’: A qualitative investigation of the factors influencing Australian health-care practitioners' delivery of medicinal cannabis
- Therapeutic Potential of Cannabinoid Profiles Identified in Cannabis L. Crops in Peru
- The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder
- An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care
- Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
- Sex-dependent effects of cannabis-induced analgesia
- Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
- Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
- An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
- A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction
- Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature
- Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
- Cannabis use after a cancer diagnosis in a population-based sample of cancer survivors
- Use of Cannabis and Cannabinoids in Patients With Cancer
- Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)
- Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands
- Documentation of medical marijuana use in cancer patients
- Opportunities for cannabis in supportive care in cancer
- Cannabinoids for adult cancer-related pain: systematic review and meta-analysis
- The Use of Medical Marijuana in Cancer
- Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis
- Cannabis use among cancer survivors in 22 states: Results from the Behavioral Risk Factor Surveillance System, 2020
- Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use
- Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience
- Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer
- Associations among marijuana use, health-related quality of life, exercise, depression and sleep in cancer survivors
- Symptom Management and Quality of Life of Palliative Cancer Patients After Being Administered with Thai Medicinal Cannabis
- The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis
- Cannabis use among recently treated cancer patients: perceptions and experiences
- Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients
- Medical Cannabis in Cancer Patients A Survey of a Community Hematology Oncology Population
- Current cannabis use and pain management among US cancer patients
- Cancer patients’ use of and attitudes towards medicinal cannabis
- Use of Medical Cannabis by Patients With Cancer: Attitudes, Knowledge, and Practice
- A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors
- Marijuana and Cannabidiol Use Prevalence and Symptom Management Among Patients with Cancer
- Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario
- Trends in cannabis use intention around the period of cannabis legalisation in Australia: An age-period-cohort model
- UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders
- Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)
- Egocentric Network Characteristics and Cannabis Use in a Sample of Young Adult Medical Cannabis Patients and Nonpatient Users
- 'The wild west of medicine': A qualitative investigation of the factors influencing Australian health-care practitioners' delivery of medicinal cannabis
- A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
- Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles
- Backgrounds and Trainings in Cannabis Therapeutics of Dispensary Personnel
- Cannabis effectiveness on immunologic potency of pulmonary contagion
- Long-term safety of medical cannabis in Parkinson's disease: A retrospective case-control study
- Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial
- Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study
- Cannabis Effects on Driving Performance: Clinical Considerations
- Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review
- Older Canadians' Perceptions of the Safety, Effectiveness and Accessibility of Cannabis for Medicinal Purposes: A Cross-Sectional Analysis
- Exploring the Link Between Attention-Deficit Hyperactivity Disorder and Cannabis Use Disorders: A Review
- Medical Cannabis in the Treatment of Parkinson's Disease
- Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review
- Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study
- The Information-Seeking Behavior and Unmet Knowledge Needs of Older Medicinal Cannabis Consumers in Canada: A Qualitative Descriptive Study
- Medical Cannabis and Its Efficacy/Effectiveness for the Treatment of Low-Back Pain: a Systematic Review
- A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis
- The Exploration of Cannabis and Cannabinoid Therapies for Migraine
- A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis
- Phytochemical Comparison of Medicinal Cannabis Extracts and Study of Their CYP-Mediated Interactions with Coumarinic Oral Anticoagulants
- Stigma, risks, and benefits of medicinal cannabis use among Australians with cancer
- Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study
- Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence
- Medicinal cannabis in neurodegenerative disorders: an open label, dose finding, safety and efficacy study
- UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention-deficit/hyperactivity disorder
- Medicinal cannabis use among young adults during California's transition from legalized medical use to adult-use: a longitudinal analysis
- Self-reported Medicinal Cannabis Use as an Alternative to Prescription and Over-the-counter Medication Use Among US Military Veterans
- Medicinal use of cannabis: A qualitative study of the perspectives of doctors and pharmacists from six African countries
- The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review
- The prevalence of cannabis use disorders in people who use medicinal cannabis: A systematic review and meta-analysis
- Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies
- Medicinal cannabis for Australian patients with chronic refractory pain including arthritis
- Medicinal cannabis products for the treatment of acute pain
- Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study
- Assessment of Medical Cannabis and Health-Related Quality of Life
- Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
- Medical Cannabis for Chronic Nonmalignant Pain Management
- Painful Subjects, Desiring Relief: Experiencing and Governing Pain in a Medical Cannabis Program
- Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies
- Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use
- Effects of prenatal THC vapor exposure on body weight, glucose metabolism, and feeding behaviors in chow and high-fat diet fed rats
- Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo
- Release of delta-9-tetrahydrocannabinol from polyvinyl alcohol hydrogels and its safe interaction with human skin fibroblasts
- Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder Get access Arrow
- Pharmacokinetic of two oral doses of a 1:20 THC:CBD cannabis herbal extract in cats
- A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood
- Cytogenotoxicity and inflammatory response in liver of rats exposed to different doses of cannabis nano emulsions
- Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors
- Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany
- Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review
- Cannabidiol use in France in 2022: Results from a nationwide representative sample of adults
- Determination of Δ9-tetrahydrocannabinol, 11-nor-carboxy-Δ9-tetrahydrocannabinol and cannabidiol in human plasma and urine after a commercial cannabidiol oil product intake
- Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review
- Medical Cannabis Patients Under the Age of 21 in the United States: Description of Demographics and Conditions from a Large Patient Database, 2019-2023
- Evidence of Cannabidiol Effectiveness Associated or Not with Tetrahydrocannabinol in Topical Administration: A Scope Review
- Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)
- Cumulative Deleterious Effects of Tetrahydrocannabinoid (THC) and Ethanol on Mitochondrial Respiration and Reactive Oxygen Species Production Are Enhanced in Old Isolated Cardiac Mitochondria
- Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines
- Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
- Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21
- Human osteoclasts in vitro are dose dependently both inhibited and stimulated by cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC)
- Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023
- Cannabinoids and the immune system: An overview
- How important are sex differences in cannabinoid action?
- Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice
- Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use
- Examining the roles of cannabinoids in pain and other therapeutic indications: a review
- Medical cannabis in pediatric oncology: a survey of patients and caregivers
- Chronic effects of cannabis use on the human reward system: An fMRI study
- Δ9-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: Possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells
- Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells
- Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol
- Developmental Effects of Cannabidiol and Δ9-Tetrahydrocannabinol in Zebrafish
- Individual and Additive Effects of the CNR1 and FAAH Genes on Brain Response to Marijuana Cues
- Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
- Structural MRI Findings in Long-Term Cannabis Users: What Do We Know?
- Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- The Cannabinoid Receptor Agonist THC Attenuates Weight Loss in a Rodent Model of Activity-Based Anorexia
- The effect of nightly use of 150 mg cannabidiol on daytime neurocognitive performance in primary insomnia: a randomized controlled pilot trial
- Prevalence and trends of suspected cannabinoid hyperemesis syndrome over an 11-year period in Northern California: An electronic health record study
- Hypothalamic cannabinoid signaling: Consequences for eating behavior
- Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review
- Limited impact of cannabidiol on health-related quality of life of people with long-term controlled HIV: a double-blind, randomized, controlled trial
- Cognitive Impairments in Adolescent Cannabis Users are Related to THC Levels
- The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks
- Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity
- Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models
- THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia
- Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients
- THC:CBD in Daily Practice: Available Data from UK, Germany and Spain
- The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
- The effects of Δ9-tetrahydrocannabinol on the dopamine system
- Nonmedical versus medical marijuana use among three age groups of adults: Associations with mental and physical health status
- Δ9-Tetrahydrocannabinol Suppresses Secretion of IFNα by Plasmacytoid Dendritic Cells From Healthy and HIV-Infected Individuals
- A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
- Effects of tetrahydrocannabinol on glucose uptake in the rat brain
- Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV− adults
- Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
- Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study
- Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial
- Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor
- Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information
- Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC
- Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation
- Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain
- Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
- A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis
- Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents
- The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation
- Treatment of Periodontal Ligament Stem Cells with MOR and CBD Promotes Cell Survival and Neuronal Differentiation via the PI3K/Akt/mTOR Pathway
- A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
- Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
- Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis Updated
- Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
- Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
- Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017-2019
- Medical Cannabis Use among Adults in the Southeastern United States
- Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care
- Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis
- The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study
- The Impact of Cannabis Consumption on Mortality, Morbidity, and Cost in Acute Pancreatitis Patients in the United States
- Illegal cannabis use is common among Danes with multiple sclerosis
- Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State
- Cannabis for pain in orthopedics: a systematic review focusing on study methodology
- Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
- Is the use of Cannabis associated with periodontitis? A systematic review and meta-analysis
- The effectiveness of self-directed medical cannabis treatment for pain
- Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects
- Driving under the influence of cannabis among medical cannabis patients with chronic pain
- Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain
- Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
- The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn’s and Colitis Foundation
- Cannabis Use for Medicinal Purposes among Canadian University Students
- Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use
- Qualifying Conditions Of Medical Cannabis License Holders In The United States
- Pulmonary effects of inhaled cannabis smoke
- A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
- Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis
- Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
- Safety and Efficacy of Medical Cannabis in Fibromyalgia
- Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies
- How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
- The protective effects of Δ9-tetrahydrocannabinol against inflammation and oxidative stress in rat liver with fructose-induced hyperinsulinemia
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
- Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
- The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray)
- Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
- Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
- Δ9-Tetrahydrocannabinol upregulates fatty acid 2-hydroxylase (FA2H) via PPARα induction: A possible evidence for the cancellation of PPARβ/δ-mediated inhibition of PPARα in MDA-MB-231 cells
- Multigenerational consequences of early-life cannabinoid exposure in zebrafish
- Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
- Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus
- Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
- Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent
- Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report
- FABP1 controls hepatic transport and biotransformation of Δ9-THC
- Cannabidiol Increases Proliferation, Migration, Tubulogenesis, and Integrity of Human Brain Endothelial Cells through TRPV2 Activation
- An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
- Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts
- Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes
- Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
- Chronic nicotine exposure attenuates the effects of Δ9-tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats
- Cannabis and Cannabinoid Biology in Stroke: Controversies, Risks, and Promises
- On the impact of cannabis consumption on traffic safety: a driving simulator study with habitual cannabis consumers
- DNA Damaging Effects, Oxidative Stress Responses and Cholinesterase Activity in Blood and Brain of Wistar Rats Exposed to Δ9-Tetrahydrocannabinol
- The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)
- Δ9-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
- Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation
- Cannabidiol (CBD) use in psychiatric disorders: A systematic review
- Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study
- Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures
- DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor
- Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
- Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials
- Probing the antioxidant activity of Δ9-tetrahydrocannabinol and cannabidiol in Cannabis sativa extracts
- Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
- Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers
- Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
- Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry
- Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors
- Effects in rats of adolescent exposure to cannabis smoke or THC on emotional behavior and cognitive function in adulthood
- Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons
- The Cerebellum, THC, and Cannabis Addiction: Findings from Animal and Human Studies
- Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone
- Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
- Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
- Regional redistribution of CB1 cannabinoid receptors in human foetal brains with Down's syndrome and their functional modifications in Ts65Dn+/+ mice
- A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability
- Cannabis and the skin
- The short-term and long-term effects of cannabis on cognition: recent advances in the field
- Cannabis based medicines and cannabis dependence: A critical review of issues and evidence
- “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
- An overview of cannabis based treatment in Crohn’s disease
- Cannabidiol in Parkinson’s disease
- Cannabis Use and Sport: A Systematic Review
- Characterizing Marijuana Use Disorders (DSM-5) — National Survey on Drug Use and Health, United States, 2020
- Cannabidiol Protects Dopaminergic Neurons in Mesencephalic Cultures against the Complex I Inhibitor Rotenone Via Modulation of Heme Oxygenase Activity and Bilirubin
- Microencapsulation of Cannabidiol in Liposomes as Coating for Cellulose for Potential Advanced Sanitary Material
- Genomic Instability in Peripheral Blood and Buccal Mucosal Cells of Marijuana Smokers: The Impact of Tobacco Smoke
- Marijuana Dependence: Not Just Smoke and Mirrors
- Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines
- Marijuana use and coronary artery disease in young adults
- Negative mood as a mediator of the association between insomnia severity and marijuana problems in college students
- The potential role of cannabinoids in dermatology
- Feline cognitive dysfunction as a model for Alzheimer’s disease in the research of CBD as a potential treatment—a narrative review
- Medical Cannabis in Children
- Long-term effects of maternal cannabis vapor exposure on emotional reactivity, social behavior, and behavioral flexibility in offspring
- A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
- Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles
- CBD-supplemented Polishing Powder Enhances Tooth Polishing by Inhibiting Dental Plaque Bacteria
- Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
- Microstructural brain abnormalities in HIV+ individuals with or without chronic marijuana use
- The level of evidence of medical marijuana use for treating disabilities: a scoping review
- Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps
- Cannabis in Pregnancy and Lactation – A Review
- Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis
- Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers
- Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
- Subacute cannabidiol alters genome-wide DNA methylation in adult mouse hippocampus
- Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
- Cannabidiol Promotes Endothelial Cell Survival by Heme Oxygenase-1-Mediated Autophagy
- Development of cannabidiol as a treatment for severe childhood epilepsies
- Effects of marijuana on human reproduction
- Medical Marijuana Effects in Movement Disorders, Focus on Huntington Disease; A Literature Review
- The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
- Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice
- The effects of cannabidiol on male reproductive system: A literature review
- Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
- Different Effects of Cannabis Abuse on Adolescent and Adult Brain
- Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia
- Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease
- Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
- Cannabidiol inhibits multiple cardiac ion channels and shortens ventricular action potential duration in vitro
- Use of cannabidiol in anxiety and anxiety-related disorders
- Opioid-enhancing antinociceptive effects of delta-9-tetrahydrocannabinol and amitriptyline in rhesus macaques
- Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
- Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice
- A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol
- Neuroprotection Following Concussion: The Potential Role for Cannabidiol
- Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy?
- Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit
- Role of cannabis in inflammatory bowel diseases
- Association of State Marijuana Legalization Policies for Medical and Recreational Use With Vaping-Associated Lung Disease
- Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain
- The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain
- Hydrogen Bonding between Tetrahydrocannabinol and Vitamin E Acetate in Unvaped, Aerosolized, and Condensed Aerosol e-Liquids
- One-Stop Microfluidic Assembly of Human Brain Organoids To Model Prenatal Cannabis Exposure
- Marijuana use and its influence on sperm morphology and motility: identified risk for fertility among Jamaican men
- Medical marijuana laws and driving under the influence of marijuana and alcohol
- Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
- Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials
- The Effects of Recreational Marijuana Legalization and Dispensing on Opioid Mortality
- Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review
- Cannabinoids as anti-ROS in aged pancreatic islet cells
- Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults
- The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations
- Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
- CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons
- PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
- Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literature
- The Impact of Cannabidiol on Psychiatric and Medical Conditions
- The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence
- The Impact of Feeding Cannabidiol (CBD) Containing Treats on Canine Response to a Noise-Induced Fear Response Test
- The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
- Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis
- Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma
- Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsy
- Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients
- A within-person comparison of the subjective effects of higher vs. lower-potency cannabis
- Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
- Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
- Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish
- Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews
- Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial
- A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
- Potential Probiotic or Trigger of Gut Inflammation – The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract
- Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption
- Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria
- Secondhand exposure from vaping marijuana: Concentrations, emissions, and exposures determined using both research-grade and low-cost monitors
- Mapping cannabis potency in medical and recreational programs in the United States
- Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy
- Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis
- The effect of tetrahydrocannabinol on testosterone among men in the United States: results from the National Health and Nutrition Examination Survey
- Potency Assessment of CBD Oils by Their Effects on Cell Signaling Pathways
- Delta-9-tetrahydrocannabinol disrupts mitochondrial function and attenuates syncytialization in human placental BeWo cells
- Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83
- Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio)
- Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
- Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs
- Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain
- Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
- CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer
- In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues
- Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta
- Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro
- Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016
- Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
- THC Regulates Tearing via Cannabinoid CB1 Receptors
- Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
- THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults
- Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
- Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
- Δ9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial
- Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance
- Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
- The The Effect of Delta-9-Tetrahydrocannabinol and Cannabidiol on Blood Flow
- Medical Cannabis to Treat Symptoms From Head and Neck Radiation Therapy
- Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder
- A descriptive study of older medical cannabis users in medical cannabis clinics
- Cannabis Extracts and Their Cytotoxic Effects on Human Erythrocytes, Fibroblasts, and Murine Melanoma
- Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users
- The effects of marijuana use prior to traumatic brain injury on survival
- The Effects of Cannabis: Implications for the Surgical Patient
- Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
- Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in vitro
- Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study
- Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis
- Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
- Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
- Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review
- Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease
- Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
- Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies
- Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
- Caring for Behavioral Symptoms of Dementia (CBD): A New Investigation into Cannabidiol for the Treatment of Anxiety and Agitation in Alzheimer's Dementia
- The Cannabinoid Delta-9-tetrahydrocannabinol Disrupts Estrogen Signaling in Human Placenta
- Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients
- Seizure and Interictal Electroencephalographic (EEG) Changes with Cannabinoid Concentrate Use
- Cannabinoid-Induced Conditioned Place Preference, Intravenous Self-Administration, and Behavioral Stimulation Influenced by Ghrelin Receptor Antagonism in Rats
- Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats
- Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature
- Endocannabinoids in immune regulation and immunopathologies
- Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (THC-AD)
- The Role of Cannabidiol in Neurological Disorders
- A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory
- ∆9-tetrahydrocannabinol self-administration induces cell-type specific adaptations in the nucleus accumbens core
- Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites
- Cannabis-Based Medicines and Pain: A Review of Potential Synergistic and Entourage Effects
- Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity
- Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
- Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
- The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review
- Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control
- Lateral habenula cannabinoid CB1 receptor involvement in drug-associated impulsive behavior
- Preinjury Use of Marijuana and Outcomes in Trauma Patients
- Medicinal cannabis in the treatment of chronic pain
- Cannabis in Parkinson’s Disease: The Patients’ View
- Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer
- Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics
- A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
- Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
- Effect of prenatal marijuana exposure on sleep wake cycles and amplitude-integrated electroencephalogram (aEEG)
- Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series
- Cannabis-induced oceanic boundlessness
- Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016
- Short-term effects of cannabis consumption on cognitive performance in medical cannabis patients
- Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
- Advancing the science on cannabis concentrates and behavioural health
- Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220)
- Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior
- Δ9-Tetrahydrocannabinol Produced Positive Place Preference in Mice without Significant Ex-Vivo Effect on Hepatic Arylamine N-Acetyltransferase Activity: Implications for Its Addictive Liability and Absence of Effect on Xenobiotic Metabolism
- Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
- A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?
- Vascular responses disrupted by fructose-induced hyperinsulinemia improved with delta-9- tetrahydrocannabinol
- Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice
- Inflammation in Adolescents With Mood Symptoms Who Use THC Compared to Non-THC Users
- Cannabis and Athletic Performance
- Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use
- Effects of ∆9-THC on memory in ovariectomized and intact female rats
- Evaluation of Cannabinoids on the Odonto/Osteogenesis in Human Dental Pulp Cells In Vitro
- Sex differences in the acute effects of oral and vaporized cannabis among healthy adults
- Neuroprotective Effects of Delta-9-Tetrahydrocannabinol against FeSO4- and H2O2-Induced Cell Damage on Dopaminergic Neurons in Primary Mesencephalic Cell Culture
- Oxidative Stress Status in Testis of Type-2 Diabetic Rats Treated with Delta-9-Tetrahydrocannabinol
- Acute Delta 9-tetrahydrocannabinol administration differentially alters the hippocampal opioid system in adult female and male rats
- An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer's Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model
- HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits
- Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?
- Behavioral Battery for Testing Candidate Analgesics in Mice. II. Effects of Endocannabinoid Catabolic Enzyme Inhibitors and ∆9-Tetrahydrocannabinol
- Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (THC-AD)
- Persistent Exposure to Δ9-Tetrahydrocannabinol during Adolescence Does Not Affect Nociceptive Responding in Adult Mice
- Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing
- Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls
- The role of Tetrahydrocannabinol in inducing disrupted signaling cascades, hippocampal atrophy and memory defects
- Δ 9-Tetrahydrocannabinol During Adolescence Reprograms the Nucleus Accumbens Transcriptome, Affecting Reward Processing, Impulsivity, and Specific Aspects of Cocaine Addiction-Like Behavior in a Sex-Dependent Manner
- Different responses of repetitive behaviours in juvenile and young adult mice to Δ9-tetrahydrocannabinol and cannabidiol may affect decision making for Tourette syndrome
- Paternal Cannabis Exposure Prior to Mating, but Not Δ9-Tetrahydrocannabinol, Elicits Deficits in Dopaminergic Synaptic Activity in the Offspring
- The Effects of Acute Δ9-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study
- Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s dementia (THC-AD)
- Adolescent administration of Δ9-THC decreases the expression and function of muscarinic-1 receptors in prelimbic prefrontal cortical neurons of adult male mice
- Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain
- Glucocorticoids, Stress and Delta-9 Tetrahydrocannabinol (THC) during Early Embryonic Development
- Intravenous self-administration of delta-9-THC in adolescent rats produces long-lasting alterations in behavior and receptor protein expression
- Miswiring the brain: Human prenatal Δ9-tetrahydrocannabinol use associated with altered fetal hippocampal brain network connectivity
- Effects of Delta-9 Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
- Novel Formulation of THC and CBN in a Repeat-Action Tablet Improves Objective and Subjective Measurements of Sleep
- Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis
- Measuring the Change in Health-Related Quality of Life in Patients Using Marijuana for Pain Relief
- Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
- Can cannabinoids still play a role as pain medications?
- Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes
- Medical Cannabis for Headache Pain: a Primer for Clinicians
- Safety of Medical Cannabis in Neuropathic Chronic Pain Management
- Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
- Effects of tetrahydrocannabinols on human oral cancer cell proliferation, apoptosis, autophagy, oxidative stress, and DNA damage
- Delta-9-tetrahydrocannabinol inhibits invasion of HTR8/SVneo human extravillous trophoblast cells and negatively impacts mitochondrial function
- Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo
- In Utero Exposure to Δ9-Tetrahydrocannabinol Leads to Postnatal Catch-Up Growth and Dysmetabolism in the Adult Rat Liver
- Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization
- Detrimental effects of adolescent escalating low-dose Δ9-tetrahydrocannabinol leads to a specific bio-behavioural profile in adult male rats
- Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain
- Impairment of Synaptic Plasticity by Cannabis, Δ9-THC, and Synthetic Cannabinoids
- THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner
- The TRPV2 channel mediates Ca2+ influx and the Δ9-THC-dependent decrease in osmotic fragility in red blood cells
- Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats
- Exposure to Δ9-tetrahydrocannabinol during rat pregnancy leads to impaired cardiac dysfunction in postnatal life
- Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats
- Pharmacokinetic, behavioral, and brain activity effects of Δ9-tetrahydrocannabinol in adolescent male and female rats
- Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review
- Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats
- Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
- A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2
- Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
- Gestational exposure to Δ9-THC impacts ovarian follicular dynamics and angiogenesis in adulthood in Wistar rats
- Effect of Δ9-Tetrahydrocannabinol on frontostriatal resting state functional connectivity and subjective euphoric response in healthy young adults
- Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex
- The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol
- Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure
- Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis
- White matter integrity after cannabidiol administration for treatment resistant epilepsy
- Cannabis use and sleep: Expectations, outcomes, and the role of age
- Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic
- Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids
- Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression
- Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
- Cannabis use and measurement of cannabinoids in plasma and breast milk of breastfeeding mothers
- UV induced changes in proteome of rats plasma are reversed by dermally applied cannabidiol
- Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting
- Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response
- Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies
- Juvenile cannabidiol chronic treatments produce robust changes in metabolic markers in adult male Wistar rats
- Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy
- A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor
- Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol
- Cannabidiol Does Not Cause Significant Changes to Working Memory Performance in the N-Back Task
- Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training
- Functional Connectivity Derived From Electroencephalogram in Pharmacoresistant Epileptic Encephalopathy Using Cannabidiol as Adjunctive Antiepileptic Therapy
- Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart
- Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial
- Cannabidiol-mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage
- Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice
- Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice
- Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
- Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol
- Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation
- Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients
- Two-center experience of cannabidiol use in adults with Dravet syndrome
- Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
- Protective effects of cannabidiol on the membrane proteins of skin keratinocytes exposed to hydrogen peroxide via participation in the proteostasis network
- Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
- Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis
- Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
- Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?
- Cannabidiol promotes neurogenesis in the dentate gyrus during an abstinence period in rats following chronic exposure to methamphetamine
- Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain
- Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs
- Behavioral and Molecular Effects Induced by Cannabidiol and Valproate Administration in the GASH/Sal Model of Acute Audiogenic Seizures
- The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
- Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal
- Disease-Dependent Antiapoptotic Effects of Cannabidiol for Keratinocytes Observed upon UV Irradiation
- Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice
- Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia
- Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential Channels
- Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol
- Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
- Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
- PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice
- Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial
- Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation
- Anti-Biofilm Activity of Cannabidiol against Candida albicans
- Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways
- Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference
- Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT1A and CB1 receptors
- Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation
- Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats
- Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity
- Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
- Long-term safety and efficacy of add-on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long-term open-label extension trial
- Cannabidiol Inhibits Tau Aggregation In Vitro
- Combined Antiseizure Efficacy of Cannabidiol and Clonazepam in a Conditional Mouse Model of Dravet Syndrome
- Protective Effects of Cannabidiol on the Membrane Proteome of UVB-Irradiated Keratinocytes
- Evaluation of cannabidiol’s inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids
- The Effect of Cannabidiol on UV-Induced Changes in Intracellular Signaling of 3D-Cultured Skin Keratinocytes
- The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial
- The electrophysiological effects of cannabidiol on action potentials and transmembrane potassium currents in rabbit and dog cardiac ventricular preparations
- Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures
- Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent
- Effects of cannabidiol (CBD) treatment in a mouse model of Alzheimer’s disease through regulation of Interleukin-5
- Cannabidiol attenuates cognitive deficits and neuroinflammation induced by early alcohol exposure in a mice model
- The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
- Antioxidant and Anti-inflammatory Effect of Cannabidiol Contributes to the Decreased Lipid Peroxidation of Keratinocytes of Rat Skin Exposed to UV Radiation
- Cannabidiol Does Not Impair Anabolic Signaling Following Eccentric Contractions in Rats
- Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials
- Cannabidiol induces autophagy via ERK1/2 activation in neural cells
- Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory
- New Insights on Hemp Oil Enriched in Cannabidiol: Decarboxylation, Antioxidant Properties and In Vitro Anticancer Effect
- Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?
- Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum
- Potential Role of Cannabidiol on Sports Recovery: A Narrative Review
- Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line
- Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials
- Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment
- Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
- Acute effects of high-potency cannabis flower and cannabis concentrates on everyday life memory and decision making
- Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice
- Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome
- Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
- The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain
- Cannabidiol Suppresses Angiogenesis and Stemness of Breast Cancer Cells by Downregulation of Hypoxia-Inducible Factors-1α
- The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination
- Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy
- Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety
- Role of marijuana components on the regenerative ability of stem cells
- A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors
- Emerging potential of cannabidiol in reversing proteinopathies
- Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat
- Cannabidiol Protects Human Skin Keratinocytes from Hydrogen-Peroxide-Induced Oxidative Stress via Modulation of the Caspase-1–IL-1β Axis
- Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice
- Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine
- Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy
- Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats
- Review of the Endocannabinoid System
- Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts
- Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins
- Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action
- Cannabidiol disrupts apoptosis, autophagy and invasion processes of placental trophoblasts
- Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome
- Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
- Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer’s Disease
- Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell
- Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
- Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
- Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects
- Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function
- Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models
- Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia
- Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases
- A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis
- Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial
- Neuroprotective Effect of Cannabidiol Against Hydrogen Peroxide in Hippocampal Neuron Culture
- Cannabidiol-Driven Alterations to Inflammatory Protein Landscape of Lipopolysaccharide-Activated Macrophages In Vitro May Be Mediated by Autophagy and Oxidative Stress
- Cannabidiol Application Increases Cutaneous Aquaporin-3 and Exerts a Skin Moisturizing Effect
- Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity
- Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma Cells
- Prevalence of Cannabinoid Use in Patients With Hip and Knee Osteoarthritis
- Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey
- Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial
- In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells
- Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels
- Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
- Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
- Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
- Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review
- Cannabidiol (CBD) improves cognition and decreases anxiety in the SAMP8 mouse model of Alzheimer’s
- Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4
- Cannabidiol modulation of oxidative stress and signalling
- Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey
- Assessing the effects of topical cannabidiol in patients with atopic dermatitis
- Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability
- Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
- Regulatory Effect of Cannabidiol (CBD) on Decreased β-Catenin Expression in Alopecia Models by Testosterone and PMA Treatment in Dermal Papilla Cells
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy
- Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
- Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
- Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
- Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey
- Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
- Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
- Impact of Smoking Cannabidiol (CBD)-Rich Marijuana on Driving Ability
- CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration
- Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review
- Cannabidiol in the Treatment of Epilepsy
- Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats
- Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons
- Effect of Cannabidiol (CBD) on Canine Inflammatory Response: An Ex Vivo Study on LPS Stimulated Whole Blood
- CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway
- Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence
- Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats
- The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis
- A cannabidiol-loaded Mg-gallate metal–organic framework-based potential therapeutic for glioblastomas
- Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments
- Approved cannabinoids for medical purposes – Comparative systematic review and meta-analysis for sleep and appetite
- Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy
- Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model
- Citalopram and Cannabidiol In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People
- Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models
- The long-term efficacy of cannabidiol in the treatment of refractory epilepsy
- Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis
- Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder
- Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence
- Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq
- CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation
- Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
- Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn’s Disease, a Randomised Controlled Trial
- Pharmacokinetic Drug–Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients
- The Impact of Cannabidiol on Human Brain Function: A Systematic Review
- Feeding Cannabidiol (CBD)-Containing Treats Did Not Affect Canine Daily Voluntary Activity
- Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials
- CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature
- CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action
- Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
- Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study
- The Impact of THC and CBD in Schizophrenia: A Systematic Review
- Neuropathic itch treated with oral cannabinoids: A case series
- Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies
- Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
- A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson’s Disease and the Potential Role of Oral Cannabinoids
- Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
- Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment
- From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia
- A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids
- Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response
- The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects
- Cannabidiol and Other Cannabinoids in Demyelinating Diseases
- Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series
- Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?
- Systematic review of the impact of cannabinoids on neurobehavioral outcomes in preclinical models of traumatic and nontraumatic spinal cord injury
- Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension
- Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy
- The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
- Mini-review: The therapeutic role of cannabinoids in neuroHIV
- Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies
- The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
- Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review
- General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews
- Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects
- The therapeutic potential of cannabinoids for integumentary wound management
- Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis
- The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study
- Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain
- Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
- Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews
- Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
- An overview on plants cannabinoids endorsed with cardiovascular effects
- Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?
- Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
- Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
- The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases
- The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
- Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
- Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
- Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
- Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management
- Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review
- Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis
- Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments
- Cannabinoid receptor 1 signalling modulates stress susceptibility and microglial responses to chronic social defeat stress
- Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
- Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders
- A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid
- Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases
- Presenting the outputs of the IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia
- A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma
- Cannabinoid receptor type 2 promotes kidney fibrosis through orchestrating β-catenin signaling
- Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
- Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
- Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo
- The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man
- Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
- Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study
- International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
- Cannabinoid Receptors in Metabolic Regulation and Diabetes
- Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
- Metabolic Consequences of Gestational Cannabinoid Exposure
- Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox
- Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
- Cannabinoids in the landscape of cancer
- Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions
- CB1 Cannabinoid Receptor Signaling and Biased Signaling
- Cannabinoid Cancer Biology and Prevention
- Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential
- Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity
- Cannabinoid treatment for autism: a proof-of-concept randomized trial
- Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
- Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the in vitro growth of bacteria and dermatophytes causing common skin diseases
- Cannabis use and the risk of periodontitis: A two-sample Mendelian randomization study
- Antibacterial, antioxidant, and haemolytic potential of silver nanoparticles biosynthesized using roots extract of Cannabis sativa plant
- Case report: Medical cannabis—warfarin drug-drug interaction
- Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
- Association of a Positive Drug Screening for Cannabis With Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids
- Association between formal thought disorder and cannabis use: a systematic review and meta-analysis
- Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)
- Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population Based Study
- The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice
- Medical Cannabis and Utilization of Nonhospice Palliative Care Services: Complements and Alternatives at End of Life
- Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates
- Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy
- The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products
- THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways
- Effects of cannabidiol (CBD) on the inhibition of melanoma cells in vitro
- Cannabidiol (CBD) and cognition in epilepsy
- Cannabinoids and chronic pelvic pain in women: Focus on endometriosis
- The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review
- Antiseizure effects of the cannabinoids in the amygdala-kindling model
- Cannabinoids for Agitation in Alzheimer's Disease
- A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease What Can We Learn From Randomized and Nonrandomized Studies?
- Treatment studies with cannabinoids in anorexia nervosa: a systematic review
- Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB1 receptor immunolabeling and subcellular structure in CA1 hippocampus of young adult male mice
- Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
- Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies
- Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review
- Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials
- Therapeutic potential of cannabinoids in combination cancer therapy
- Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases
- Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression
- Cannabinoid receptor activation acutely increases synaptic vesicle numbers by activating synapsins in human synapses
- Prospects for the Use of Cannabinoids in Psychiatric Disorders
- Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence
- Endocannabinoids, cannabinoids and the regulation of anxiety
- Cannabinoid polymorphisms interact with plasma endocannabinoid levels to predict fear extinction learning
- Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials
- Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats
- Cannabinoids and the eye
- The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies
- The Cannabinoid CB1 Receptor in Schizophrenia
- Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder
- Microglial Cannabinoid Type 1 Receptor Regulates Brain Inflammation in a Sex-Specific Manner
- The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
- Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials
- Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial
- Cannabis and cannabinoids: pharmacology and therapeutic potential
- Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome
- Use of cannabidiol in the treatment of epilepsy
- Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry
- Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease
- The Use of Cannabis and Its Effects on Postpartum Depression
- Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities
- NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes
- Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews
- Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway
- Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients
- Patient Experience and Perspective on Medical Cannabis as an Alternative for Musculoskeletal Pain Management
- The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review
- Spinal astroglial cannabinoid receptors control pathological tremor
- Cannabinoid signalling and effects of cannabis on the male reproductive system
- Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization
- The cannabinoid system and microglia in health and disease
- Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study
- Safety and Efficacy of the Therapeutic Use of Cannabis-Based Products in the Treatment of Dogs: An Integrative Review
- Prenatal cannabis exposure predicts attention problems, without changes on fMRI in adolescents
- Effects of regular cannabis and nicotine use on acute stress responses: chronic nicotine, but not cannabis use, is associated with blunted adrenocortical and cardiovascular responses to stress
- Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III
- Cannabis and End-of-Life Care: A Snapshot of Hospice Planning and Experiences Among Illinois Medical Cannabis Patients With A Terminal Diagnosis
- Cannabis Cessation, Inflammatory Markers and Schizophrenia
- The Effect of Preoperative Cannabis Use on Postoperative Pain Following Gynaecologic Oncology Surgery
- Cannabis Sativa L. Flower and Bud Extracts Inhibited In vitro Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease
- Cannabis use is associated with prevalent coronary artery disease
- A scoping review on the effect of cannabis on pain intensity in people with spinal cord injury
- “I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums
- Oxidative Stress and Autophagy Mediate Anti-Cancer Properties of Cannabis Derivatives in Human Oral Cancer Cells
- The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls
- Cannabis alters DNA methylation at maternally imprinted and autism candidate genes in spermatogenic cells
- Cannabis use among patients with cutaneous lymphoma: A cross-sectional survey
- Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum
- Cannabis Use and Resting State Functional Connectivity in the Aging Brain
- Effects of recreational cannabis on testicular function in primary infertile men
- Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
- The relation between cannabis use, dependence severity and white matter microstructure: A diffusion tensor imaging study
- Multimodal MRI data fusion reveals distinct structural, functional and neurochemical correlates of heavy cannabis use
- Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis
- Indeterminacy of cannabis impairment and ∆9-tetrahydrocannabinol (∆9-THC) levels in blood and breath
- Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?
- The Pharmacogenetics of Cannabis in the Treatment of Chronic Pain
- Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice
- UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes
- Cannabis use in Parkinson’s disease—A nationwide online survey study
- Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry
- Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia
- Bayesian causal network modeling suggests adolescent cannabis use accelerates prefrontal cortical thinning
- Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015
- Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study
- Cannabis Use and the Endocannabinoid System: A Clinical Perspective
- Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies
- Prospective associations between sleep disturbances and cannabis use among Veterans: A behavioral economic approach
- Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview
- Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control
- Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
- Is resting-state functional connectivity altered in regular cannabis users? A systematic review of the literature
- Increase in Cannabis Use Among Adults With Rheumatic Diseases: Results From a 2014–2019 United States Observational Study
- Self-Reported Effects of Cannabis on ADHD Symptoms, ADHD Medication Side Effects, and ADHD-Related Executive Dysfunction
- Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review
- Tolerance for specific negative affective states and coping-oriented cannabis use motives among college student cannabis users
- Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review
- Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand
- Association between cannabis use and suicidal behavior: A systematic review of cohort studies
- Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score
- Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences
- Does cannabis use impact cognitive behavioural therapy outcomes for anxiety and related disorders? A preliminary examination
- The Effects of Consuming Cannabis Flower for Treatment of Fatigue
- Tolerability of High-Dose Oral Δ9-THC: Implications for Human Laboratory Study Design
- Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation
- Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications
- Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
- Sperm DNA methylation alterations from cannabis extract exposure are evident in offspring
- The Effects of Cannabis Use during Pregnancy on Low Birth Weight and Preterm Birth: A Systematic Review and Meta-analysis
- Insilico inquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration
- Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
- Recent cannabis use and nightly sleep duration in adults: a population analysis of the NHANES from 2005 to 2018
- Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety
- Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
- Use of Cannabis and Cannabinoids for Treatment of Cancer
- Cannabis for Rheumatic Disease Pain: a Review of Current Literature
- Aberrant hippocampal shape development in young adults with heavy cannabis use: Evidence from a longitudinal study
- Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review
- Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses
- Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study
- Maternal cannabis use during pregnancy and maternal and neonatal outcomes: A retrospective cohort study
- Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls
- Long-term effects of prenatal cannabis exposure: Pathways to adolescent and adult outcomes
- Evaluating Cannabis sativa L.’s neuroprotection potential: From bench to bedside
- The Effectiveness of Common Cannabis Products for Treatment of Nausea
- Cannabis and orofacial pain: a systematic review
- Cannabis for Medical Use: Analysis of Recent Clinical Trials in View of Current Legislation
- Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells
- Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants
- Cannabis in Palliative Care: A Systematic Review of Current Evidence
- Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment
- Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context
- Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey
- Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature
- Mental health and quality of life in a population of recreative cannabis users in Brazil
- A critical review of cannabis in medicine and dentistry: A look back and the path forward
- Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans
- Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms
- Adult Psychiatric, Substance, and Functional Outcomes of Different Definitions of Early Cannabis Use
- Cannabis Use in Patients With Cancer: A Clinical Review
- Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017
- An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample
- Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain
- Differential Effects of Cannabis and Tobacco on Lung Function in Mid–Adult Life
- Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
- Effects of Cannabis on PTSD Recovery: Review of the Literature and Clinical Insights
- Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain A Systematic Review and Meta-analysis
- Is There a Place for Medicinal Cannabis in Treating Patients with Sleep Disorders? What We Know so Far
- Broad-spectrum cannabis oil ameliorates reserpine-induced fibromyalgia model in mice
- Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
- Effects of Cannabis in Parkinson’s Disease: A Systematic Review and Meta-Analysis
- The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
- Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry
- Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife
- Sex differences in medical cannabis-related adverse effects
- Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms
- Medicinal Cannabis and Central Nervous System Disorders
- Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study
- Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids
- Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports
- Clinical Relevance of Drug Interactions with Cannabis: A Systematic Review
- UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder
- The effect of medical cannabis on cognitive functions: a systematic review
- A survey of medical cannabis use during perimenopause and postmenopause
- Functional brain connectomes reflect acute and chronic cannabis use
- Novel Insights into Potential Cannabis-Related Cancerogenesis from Recent Key Whole Epigenome Screen of Cannabis Dependence and Withdrawal: Epidemiological Commentary and Explication of Schrott et al.
- Factors that Impact the Pharmacokinetic and Pharmacodynamic Effects of Cannabis: a Review of Human Laboratory Studies
- Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)
- Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use
- U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020
- Cannabinoids accumulate in mouse breast milk and differentially regulate lipid composition and lipid signaling molecules involved in infant development
- Cannabis and metformin on diabetic male Wistar rat sperm and reproductive organ parameters
- Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges
- Rate of cannabis use in older adults with cancer
- Plant-derived cannabinoids as anticancer agents
- Intrauterine cannabis exposure and fetal and maternal blood flow: a case–control study
- Inhibitory Effects of Major Cannabinoids and their Metabolites on Oxazepam Metabolism
- Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts
- PMON252 Δ-9-tetrahydrocannabinol does not affect motility, morphology or viability, but alters the transcriptome of cryopreserved sperm
- Treatment with Cannabidiol Results in an Antioxidant and Cardioprotective Effect in Several Pathophysiologies
- Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls
- Updates in the use of cannabis for insomnia
- Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action
- Cannabis and Psychosis: Recent Epidemiological Findings Continuing the “Causality Debate”
- In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center
- Cannabis Exposure Decreases Need for Blood Pressure Support During General Anesthesia in Orthopedic Trauma Surgery
- Neuroprotective potential of Cannabis sativa-based oils in Caenorhabditis elegans
- A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
- The Detrimental Effects of Cannabis on Brain. A Concise Review
- Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction
- Acute effects of cannabinoid consumption on endocannabinoid levels
- Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model
- Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients
- The Neurotoxic Effects of Cannabis on Brain: Review of Clinical and Experimental Data
- Comparing Sublingual and Inhaled Cannabis Therapies for Low Back Pain: An Observational Open-Label Study
- Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry
- The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians
- The Relationship Between Cannabis Use and Self-Reported Trait Anger in Treatment-Seeking Young People
- Cannabis consumption and prosociality
- Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands
- A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain
- Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study
- Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
- Marijuana and endothelial dysfunction: new mechanism and therapy
- Medicinal Cannabis for the Treatment of Anxiety Disorders: a Narrative Review
- Medical Cannabis for Gynecologic Pain Conditions
- Prosocial Effects of Nonpsychotropic Cannabis sativa in Mice
- Medicinal cannabis for chronic pain: The bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations
- A Systematic Review of Medical Cannabinoids Dosing in Human
- Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis
- Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada
- Inhibition of human androgen receptor by delta 9-tetrahydro-cannabinol and cannabidiol related to reproductive dysfunction: A computational study
- Marijuana and thromboembolic events in geriatric trauma patients: The cannabinoids clots correlation!
- Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland
- The cannabis paradox: contrasting role for marijuana in cardiovascular disease
- Higher Risk, Higher Reward? Self-Reported Effects of Real-World Cannabis Use in Parkinson's Disease
- Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists
- Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
- Association of Cannabis Use With Nausea and Vomiting of Pregnancy
- Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents
- Cannabinoid control of gingival immune activation in chronically SIV-infected rhesus macaques involves modulation of the indoleamine-2,3-dioxygenase-1 pathway and salivary microbiome
- Evaluation of the Possible Anticonvulsant Effect of Δ9-Tetrahydrocannabinolic Acid in Murine Seizure Models
- Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs
- Sex-dependent Effect of In-utero Exposure to Δ9-Tetrahydrocannabinol on Glucagon and Stathmin-2 in Adult Rat Offspring
- Modulation of Recombinant Human T-Type Calcium Channels by Δ9-Tetrahydrocannabinolic Acid In Vitro
- Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization
- EVIDENCE FOR DIFFERENTIAL EFFECTS OF Δ9-THC (Δ9-TETRAHYDROCANNABINOL) ON PRE- VERSUS POST-IMPLANTATION EMBRYONIC STEM CELLS
- The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity
- Changes in Expression of DNA-Methyltransferase and Cannabinoid Receptor mRNAs in Blood Lymphocytes After Acute Cannabis Smoking
- Chronic adolescent exposure to cannabis in mice leads to sex-biased changes in gene expression networks across brain regions
- Cannabis-Based Products for Chronic Pain
- Anti-inflammatory potential of delta-9-tetrahydrocannabinol in hyperinsulinemia: an experimental study
- Driving Performance and Cannabis Users’ Perception of Safety A Randomized Clinical Trial
- Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac Myocytes
- Cannabinoid modulation of brain activation during volitional regulation of negative affect in trauma-exposed adults
- Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
- Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy- A Case Series
- Analysis of toxicity effects of delta-9-tetrahydrocannabinol on isolated rat heart mitochondria
- Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder
- Preclinical Models of THC and Nicotine Exposure During Adolescent Brain Development: Modeling Neuropsychiatric Phenotypes Related to Dopaminergic Transmission
- Inhibition of mitochondrial permeability transition pore and antioxidant effect of Delta-9-tetrahydrocannabinol reduces aluminium phosphide-induced cytotoxicity and dysfunction of cardiac mitochondria
- Vaping tetrahydrocannabinol unmasks Brugada pattern and induces ventricular fibrillation in Brugada syndrome: a case report
- The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use
- Chronic exposure to delta-9-tetrahydrocannabinol impacts testicular volume and male reproductive health in rhesus macaques
- Recovery from Traumatic Brain Injury Following Treatment with Δ9-Tetrahydrocannabinol Is Associated with Increased Expression of Granulocyte-Colony Stimulating Factor and Other Neurotrophic Factors
- Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol
- Delta-9-tetrahydrocannabinol increases vascular endothelial growth factor (VEGF) secretion through a cyclooxygenase-dependent mechanism in rat granulosa cells
- Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain
- Frequent Low-Dose Δ9-Tetrahydrocannabinol in Adolescence Disrupts Microglia Homeostasis and Disables Responses to Microbial Infection and Social Stress in Young Adulthood
- Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models
- A Review of On the Psychobiological Differences among Tetrahydrocannabinol, Cannabinol, Cannabidiol and Cannabigerol
- Administration of Δ9-Tetrahydrocannabinol Following Controlled Cortical Impact Restores Hippocampal-Dependent Working Memory and Locomotor Function
- Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence
- Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysis
- Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft
- The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects
- Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats
- Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases
- Animal evidence considered in determination of cannabis smoke and Δ9-tetrahydrocannabinol as causing reproductive toxicity (developmental endpoint): Part III. Proposed neurodevelopmental mechanisms of action
- Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice
- Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells
- Chronic delta-9-tetrahydrocannabinol (THC) treatment counteracts SIV-induced modulation of proinflammatory microRNA cargo in basal ganglia-derived extracellular vesicles
- Δ9-Tetrahydrocannabinol (Δ9-THC) Improves Ischemia/Reperfusion Heart Dysfunction and Might Serve as a Cardioprotective Agent in the Future Treatment
- Thromboembolic Outcomes in Tetrahydrocannabinol-Positive Trauma Patients With Traumatic Brain Injury
- Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol
- Potential Pro-Inflammatory Effect of Vitamin E Analogs through Mitigation of Tetrahydrocannabinol (THC) Binding to the Cannabinoid 2 Receptor
- An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model
- Chronic prenatal delta-9-tetrahydrocannabinol exposure adversely impacts placental function and development in a rhesus macaque model
- Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects
- Adolescent THC exposure: effects on pain-related, exploratory, and consummatory behaviors in adult male vs. female rats
- In the Swim of Cannabis: Developmental Toxicity and Metabolomic Pathway Alterations of Zebrafish Larvae Exposed to THC for the Assessment of Its Potential Environmental and Human Health Impact
- Prenatal Exposure to Delta-9-tetrahydrocannabinol (THC) Alters the Expression of miR-122-5p and Its Target Igf1r in the Adult Rat Ovary
- “Flower Power”: Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients
- Prenatal Δ9-Tetrahydrocannabinol Exposure in Males Leads to Motivational Disturbances Related to Striatal Epigenetic Dysregulation
- Prenatal THC Exposure Induces Sex-Dependent Neuropsychiatric Endophenotypes in Offspring and Long-Term Disruptions in Fatty-Acid Signaling Pathways Directly in the Mesolimbic Circuitry
- Persistent sexually dimorphic effects of adolescent THC exposure on hippocampal synaptic plasticity and episodic memory in rodents
- THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet
- The effects of acute Cannabis smoke or Δ9-THC injections on the trial-unique, nonmatching-to-location and five-choice serial reaction time tasks in male Long-Evans rats
- Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function
- Δ9-THC reduces reward-related brain activity in healthy adults
- Behavioral effects on the offspring of rodent mothers exposed to Tetrahydrocannabinol (THC): A meta-analysis
- Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts
- Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging
- Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review
- Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis
- Effects of phytocannabinoids on heart rate variability and blood pressure variability in female post-concussion syndrome patients: case series
- A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells
- Cannabidiol prevents depressive-like behaviors through the modulation of neural stem cell differentiation
- Medicinal cannabis for the treatment of anxiety disorders
- Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-κB-mediated signaling
- Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis
- Phytocannabinoids Stimulate Rejuvenation and Prevent Cellular Senescence in Human Dermal Fibroblasts
- Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus
- Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy
- Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy
- Anti-inflammatory effects of cannabidiol against lipopolysaccharides in cardiac sodium channels
- Cannabidiol Improves Random-Pattern Skin Flap Survival in Rats: Involvement of Cannabinoid Type-2 Receptors
- Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study
- Cannabinoid use is enhanced by stress and changes conditioned stress responses
- Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacists
- Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription
- A natural history study of medical cannabis consumption in pediatric autism in the United States
- CBD formulation improves energetic homeostasis in dermal fibroblasts from Gulf War Illness patients
- Immunosuppressive activity of non-psychoactive Cannabis sativa L. extract on the function of human T lymphocytes
- The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis
- Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
- Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway
- Cannabidiol attenuates methamphetamine-induced cardiac inflammatory response through the PKA/CREB pathway in rats
- In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer
- Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study
- Observational study of medical marijuana as a treatment for treatment-resistant epilepsies
- Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
- Biological effects of cannabidiol on human cancer cells: Systematic review of the literature
- Effects of Cannabidiol on Parkinson’s Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis
- Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke
- Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents
- Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
- Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study
- Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg
- Effects of Epidiolex® (Cannabidiol) on seizure-related emergency department visits and hospital admissions: A retrospective cohort study
- The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
- The Combination of Δ9-Tetrahydrocannabinol and Cannabidiol Suppresses Mitochondrial Respiration of Human Glioblastoma Cells via Downregulation of Specific Respiratory Chain Proteins
- Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study
- Effect of cannabidiol on schizophrenia based on randomized controlled trials: A meta-analysis
- Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study
- Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
- Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice
- Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
- Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson’s disease
- Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic–Ischemic Newborn Piglets
- Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy
- Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial
- Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats
- Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety
- A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge
- Cannabidiol treatment prevents drug reinstatement and the molecular alterations evoked by amphetamine on receptors and enzymes from dopaminergic and endocannabinoid systems in rats
- Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
- Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity
- An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy
- Cannabidiol Does Not Impact Acute Anabolic or Inflammatory Signaling in Skeletal Muscle In Vitro
- Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction
- Buccally Absorbed Cannabidiol Shows Significantly Superior Pain Control and Improved Satisfaction Immediately After Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, Double-Blinded, Randomized Trial
- Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model
- Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats
- Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats
- Cannabidiol-loaded injectable chitosan-based hydrogels promote spinal cord injury repair by enhancing mitochondrial biogenesis
- Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence
- Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
- Modification of the hemodynamic and molecular features of phosphine, a potent mitochondrial toxicant in the heart, by cannabidiol
- Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs
- Effects of Cannabidiol on Locomotor Activity
- Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
- Cytotoxic Effects of Cannabidiol on Neonatal Rat Cortical Neurons and Astrocytes: Potential Danger to Brain Development
- The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure
- Functional interactions between cannabinoids, omega-3 fatty acids, and peroxisome proliferator-activated receptors: Implications for mental health pharmacotherapies
- Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1
- Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy
- Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
- Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6
- A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis
- Cannabidiol markedly alleviates skin and liver fibrosis
- Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study
- Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction
- Cannabidiol Interferes with Establishment of Δ9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT1A Mechanism
- Potential Combinatory Effect of Cannabidiol and Triclosan Incorporated into Sustained Release Delivery System against Oral Candidiasis
- Cannabidiol activates PINK1-Parkin-dependent mitophagy and mitochondrial-derived vesicles
- Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover Study
- Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy
- Combinations of Cannabidiol and Δ9-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
- Cannabidiol in canine epilepsy
- Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein
- Cannabidiol and SARS-CoV-2 Infection
- The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
- Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
- Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
- Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery
- Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
- The Effects of Cannabidiol on Aqueous Humor Outflow and Trabecular Meshwork Cell Signaling
- Prophylactic Administration of Cannabidiol Reduces Microglial Inflammatory Response to Kainate-Induced Seizures and Neurogenesis
- Cannabidiol Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in the Inflammatory Microenvironment via the CB2-dependent p38 MAPK Signaling Pathway
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
- Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
- Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments
- The Effect of Cannabidiol Coated by Nano-Chitosan on Learning and Memory, Hippocampal CB1 and CB2 Levels, and Amyloid Plaques in an Alzheimer’s Disease Rat Model
- An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
- In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls
- Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028) †
- Young adults’ knowledge, perceptions and use of cannabidiol products: a mixed-methods study
- Cannabidiol Loaded Topical Ophthalmic Nanoemulsion Lowers Intraocular Pressure in Normotensive Dutch-Belted Rabbits
- Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone
- Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model
- The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
- Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
- Anticancer and chemosensitization effects of cannabidiol in 2D and 3D cultures of TNBC: involvement of GADD45α, integrin-α5, -β5, -β1, and autophagy
- Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network
- Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage
- Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models
- Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
- Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures
- Protective effect and mechanism of cannabidiol on myocardial injury in exhaustive exercise training mice
- Cannabidiol induces autophagy and improves neuronal health associated with SIRT1 mediated longevity
- Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties
- Cannabidiol for Functional Dyspepsia With Normal Gastric Emptying: A Randomized Controlled Trial
- Neuroprotection of cannabidiol in epileptic rats: Gut microbiome and metabolome sequencing
- Inflammation-targeted cannabidiol-loaded nanomicelles for enhanced oral mucositis treatment
- Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation
- Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I)
- Anti-Bacterial Effect of Cannabidiol against the Cariogenic Streptococcus mutans Bacterium: An In Vitro Study
- Biophysical Studies and In Vitro Effects of Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes
- Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
- A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development
- Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways
- Photoprotective Effects of Cannabidiol against Ultraviolet-B-Induced DNA Damage and Autophagy in Human Keratinocyte Cells and Mouse Skin Tissue
- Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative Review
- Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
- Cannabidiol Decreases Intestinal Inflammation in the Ovariectomized Murine Model of Postmenopause
- Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson’s Disease Mice Via Regulating Neuronal Apoptosis and Neuroinflammation
- Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes
- Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
- Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
- Cannabidiol Inhibits Inflammation Induced by Cutibacterium acnes-Derived Extracellular Vesicles via Activation of CB2 Receptor in Keratinocytes
- Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1
- Cannabidiol Regulates PPARγ-Dependent Vesicle Formation as well as Cell Death in A549 Human Lung Cancer Cells
- Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
- Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
- Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages
- Variability in Serum Concentrations and Clinical Response in Artisanal Versus Pharmaceutical Cannabidiol Treatment of Pediatric Pharmacoresistant Epilepsy
- The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: A balanced placebo design trial
- Cannabidiol in the context of substance use disorder treatment: A systematic review
- Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups
- In utero exposure to cannabidiol disrupts select early-life behaviors in a sex-specific manner
- Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Effect of combining CBD with standard breast cancer therapeutics
- The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation
- Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats
- Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain
- Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial
- Use and Perceptions of Cannabidiol Products in Canada and in the United States
- Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice
- Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry
- A Pilot Study on the Use of Low Doses of CBD to Control Seizures in Rare and Severe Forms of Drug-Resistant Epilepsy
- Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella enterica subsp. Enterica serovar typhimurium
- High dose cannabidiol (CBD) in the treatment of new-onset refractory status epilepticus (NORSE)
- Fabrication and Preliminary In Vitro Evaluation of 3D-Printed Alginate Films with Cannabidiol (CBD) and Cannabigerol (CBG) Nanoparticles for Potential Wound-Healing Applications
- Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)
- Perinatal CBD or THC Exposure Results in Lasting Resistance to Fluoxetine in the Forced Swim Test: Reversal by Fatty Acid Amide Hydrolase Inhibition
- Cannabidiol (CBD) Protects Adipose-Derived Mesenchymal Stem Cells (ASCs) against Endoplasmic Reticulum Stress Development and Its Complications
- Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
- Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
- Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
- A scoping review of the use of cannabidiol in psychiatric disorders
- Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma
- Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli
- Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against Salmonella typhimurium and S. newington
- CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome
- The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
- High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs
- Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue
- New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts
- Cannabidiol (CBD) in Cancer Management
- A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
- Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies
- Acute and long-term effects of cannabinoids on hypertension and kidney injury
- Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro
- Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
- α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa
- Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer
- Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment
- Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges
- Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation
- Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease
- “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
- Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials
- Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges
- Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes
- Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
- Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection
- Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition
- Cannabinoids, Insomnia, and Other Sleep Disorders
- Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model
- Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand
- Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- The effects of cannabis and cannabinoids on the endocrine system
- Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report
- Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes
- Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
- In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
- Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors
- Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
- Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice
- Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
- Impact of Cannabinoid Compounds on Skin Cancer
- Cannabinoids: Therapeutic Use in Clinical Practice
- New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis
- Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance
- Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
- Cannabinoid control of hippocampal functions: the where matters
- Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis
- The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study
- Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
- Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy
- Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism
- Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability
- Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
- The nonpsychoactive cannabis constituent cannabidiolis an oral anti-arthritic therapeutic in murinecollagen-induced arthritis
- Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man
- Cannabidiol Modulates M-Type K+ and Hyperpolarization-Activated Cation Currents
- Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord
- Cannabinoid receptor 2 signal promotes type 2 immunity in the lung
- Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults
- Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
- Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status
- Relief of nocturnal neuropathic pain with the use of cannabis in a patient with Fabry disease
- Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler
- The endocannabinoid system and orofacial pains: updates and perspectives
- Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain
- Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
- The Place of Cannabinoids in the Treatment of Gynecological Pain
- Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach
- Exploring potential anti-inflammatory effects of medicinal cannabis
- The Effect of Route of Administration and Vehicle on the Pharmacokinetics of THC and CBD in Adult, Neonate, and Breastfed Sprague-Dawley Rats
- Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease
- Effects of Cannabidiol on the Functions of Chimeric Antigen Receptor T Cells in Hematologic Malignancies
- Prenatal Cannabinoid Exposure Elicits Memory Deficits Associated with Reduced PSA-NCAM Expression, Altered Glutamatergic Signaling, and Adaptations in Hippocampal Synaptic Plasticity
- Cannabinoid treatments in epilepsy and seizure disorders
- Non-Intoxicating Cannabinoids in Visceral Pain
- Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
- Evaluation of different phytochemicals from Cannabis sativa against Myelin oligodendrocyte glycoprotein receptor
- Neuro-Gastro-Cannabinology: A Novel Paradigm for Regulating Mood and Digestive Health
- Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions
- Complex Regional Pain Syndrome Type I: Evidence for the CB1 and CB2 Receptors Immunocontent and Beneficial Effect of Local Administration of Cannabidiol in Mice
- Venous thromboembolism and cannabis consumption, outcomes among hospitalized patients in the United States: A nationwide analysis
- Promoting effects of cannabidiol on neurite growth and neuronal development in neuron-astrocyte sandwich coculture
- Efficacy and Safety of Medical Cannabis in Neuropathic Pain Patients
- Association of cannabis use with patient-reported pain measures among adults with chronic pain in US states with medical cannabis programs
- Drug interactions with Cannabis sativa: Mechanisms and clinical implication
- Effects of Two Cannabidiol Oil Products on Self-Reported Stress Relief: A Quasi-Experimental Study
- An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development
- Empathy-related differences in the anterior cingulate functional connectivity of regular cannabis users when compared to controls
- A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
- Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics
- Effectiveness of Cannabidiol to Manage Chronic Pain: A Systematic Review
- The use of cannabidiol (CBD) as an analgesic component
- An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release
- Regular cannabis use alters the neural dynamics serving complex motor control
- Wound healing efficacy of Cannabis sativa L. essential oil in a mouse incisional wound model: A possible link with stress and anxiety
- High-THC Cannabis smoke impairs incidental memory capacity in spontaneous tests of novelty preference for objects and odors in male rats
- Medical cannabis for refractory cancer-related pain in a specialised clinical service: a cross-sectional study
- Unlocking the Healing Potential Cannabinoids in Spine Surgery for Pain Relief and Recovery
- Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABAA Receptors
- Prevalence and Frequency of Cannabis Use Among Adults Ages 50-80 in the United States
- Cannabidiol protects the liver from α-Amanitin-induced apoptosis and oxidative stress through the regulation of Nrf2
- Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration
- Identification of Anti-Neuroinflammatory Bioactive Compounds in Essential Oils and Aqueous Distillation Residues Obtained from Commercial Varieties of Cannabis sativa L.
- Metallothionein Family Proteins as Regulators of Zinc Ions Synergistically Enhance the Anticancer Effect of Cannabidiol in Human Colorectal Cancer Cells
- Cannabis oil: Effects on Cannabinoid-Induced Tetrad, blood pressure and metabolic parameters in female rats fed a sucrose-rich diet
- Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study
- THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
- Unraveling the Link: Cannabis Use Disorder and Pulmonary Embolism-Related Hospital Outcomes in Female Breast Cancer Survivors
- Therapeutic use of medical Cannabis in neurological diseases: a clinical update
- Mental health adverse events with cannabis use diagnosed in the Emergency Department: what are we finding now and are our findings accurate?
- The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study
- Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System
- Cannabis sativa-based oils against aluminum-induced neurotoxicity
- Weight loss outcomes are not compromised in bariatric patients using cannabis
- First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation
- The effect of prenatal cannabis exposure on offspring preterm birth: a cumulative meta-analysis
- Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada
- Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease
- Effects of inhaled cannabis high in Δ9-THC or CBD on the aging brain: A translational MRI and behavioral study
- Investigating the Biological Activities of Moroccan Cannabis Sativa L Seed Extracts: Antimicrobial, Anti-inflammatory, and Antioxidant Effects with Molecular Docking Analysis
- Comparative Investigation of Antimicrobial and Antioxidant Effects of the Extracts from the Inflorescences and Leaves of the Cannabis sativa L. cv. strawberry
- Impact of prenatal cannabis exposure on functional connectivity of the salience network in children
- Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model
- The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder
- Cannabis use during lactation may alter the composition of human breast milk
- Cannabis use patterns in drug-resistant and pharmacoresponsive epilepsy: Single tertiary referral center survey investigation
- Cannabis Pharmacogenomics: A Path to Personalized Medicine
- Cannabis use for exercise recovery in trained individuals: a survey study
- Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder
- Ratings of executive function as a risk factor for adolescents’ frequent cannabis use: A prospective longitudinal study
- The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
- Cannabis and emotion processing: A review of behavioral, physiological, and neural responses
- Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions
- Cannabis use for Sleep Disturbance Among Older Patients in a Geriatrics Clinic
- Fatty acids and minor functional compounds of hemp (Cannabis sativa L.) seeds and other Cannabaceae species
- Antifungal and antibacterial activities of Cannabis sativa L. resins
- Investigation of Cannabis sativa Phytochemicals as Anti-Alzheimer’s Agents: An In Silico Study
- Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis
- Daily cannabis use may cause cannabis-induced hyperalgesia
- Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications
- Suicidality risk after using cannabis and cannabinoids: An umbrella review
- Determining impacts of prenatal cannabis exposure on cannabis vapor self-administration using a novel response-contingent vapor model in pregnant rat dams
- Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma
- Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions
- Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study
- Differences in cannabis use characteristics, routines, and reasons for use among individuals with and without a medical cannabis card
- A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome
- The Effect of Cannabis Plant Extracts on Head and Neck Squamous Cell Carcinoma and the Quest for Cannabis-Based Personalized Therapy
- Medical Cannabis in Hand Surgery: A Review of the Current Evidence
- Comparative evaluation of ethyl acetate and n-Hexane extracts of Cannabis sativa L. leaves for muscle function restoration after peripheral nerve lesion
- Cannabis as antivirals
- Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool
- Clinical, Cognitive, and Neurobiological Correlates of Impaired Timing Abilities Associate to Cannabis Use: a Systematic Review
- Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies
- Computational Study on the Enzyme–Ligand Relationship between Cannabis Phytochemicals and Human Acetylcholinesterase: Implications in Alzheimer’s Disease
- A cross-sectional survey of the prevalence and patterns of using cannabis as a sleep aid in Canadian cancer survivors
- The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?
- Vaporized cannabis extract–induced antinociception in male vs female rats with persistent inflammatory pain
- Increasing Use of Cannabis for Medical Purposes Among U.S. Residents, 2013–2020
- Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
- Cannabis and Pregnancy: A Review
- Effect of Cannabis on Memory Consolidation, Learning and Retrieval and Its Current Legal Status in India: A Review
- Association between cannabis use disorder and schizophrenia stronger in young males than in females
- Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns
- Cannabis use among adults undergoing cancer treatment
- In Vitro Antiproliferative Effect of Cannabis Extract PHEC-66 on Melanoma Cell Lines
- Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
- Prenatal risk factors and postnatal cannabis exposure: Assessing dual models of schizophrenia-like rodents
- The role of cannabis in treatment-resistant fibromyalgia women
- Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study
- An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry
- Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes
- Association between cannabis use and blood pressure levels according to comorbidities and socioeconomic status
- Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns
- Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases
- Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis
- Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
- An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry
- Determining Antioxidant Activity of Cannabis Leaves Extracts from Different Varieties—Unveiling Nature’s Treasure Trove
- The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry
- Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence
- The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study
- Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
- Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study
- Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
- Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs
- Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis
- Differential associations of adolescent versus young adult cannabis initiation with longitudinal brain change and behavior
- A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment
- Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells
- A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
- Cannabinoids for Medical Use A Systematic Review and Meta-analysis
- Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies
- A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
- Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer
- Benefits and harms of medical cannabis: a scoping review of systematic reviews
- Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting
- Clinical uses of cannabis and cannabinoids in the United States
- Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
- Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures
- Use of Marijuana for Medical Purposes among Adults in the United States
- The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder
- Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis
- Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary
- The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
- Antidepressant-like effects of Δ⁹-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression
- Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L
- Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial
- Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study
- A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
- Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
- Subjective and physiological effects after controlled Sativex and oral THC administration
- Action of cannabidiol on the anxiety and other effects produced by δ9-THC in normal subjects
- Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
- Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- Abrupt withdrawal of cannabidiol (CBD): A randomized trial
- Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats
- The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
- Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience
- Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
- Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders
- Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
- Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
- Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy
- Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study
- Nabilone for the treatment of pain in fibromyalgia
- The association between cannabis use and anxiety disorders: Results from a population-based representative sample
- Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies
- The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies
- The time course and significance of cannabis withdrawal
- Dissociation of the pharmacological effects of THC by mTOR blockade
- Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission
- Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study
- Single-dose study of nabilone in anxious volunteers
- Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use
- Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy
- Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey
- Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders
- Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
- Marijuana use among patients with epilepsy at a tertiary care center
- Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
- Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
- The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment
- Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
- Cannabis Use Patterns and Motives: A Comparison of Younger, Middle-Aged, and Older Medical Cannabis Dispensary Patients
- Factors associated with alcohol consumption among medical cannabis patients with chronic pain
- Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain
- Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users
- Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study
- Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993–2014
- Association between medical cannabis laws and opioid overdose mortality has reversed over time
- Prevalence of Marijuana Use Disorders in the United States Between 2001–2002 and 2012–2013
- US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users
- Molecular Targets of the Phytocannabinoids-A Complex Picture
- Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
- Cannabidiol improves thyroid function via modulating vitamin D3 receptor in vitamin D3 deficiency diet-induced rat model
- Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats
- Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats
- Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases
- Thymol has beneficial effects on the experimental model of ulcerative colitis
- Thymol modulates the endocannabinoid system and gut chemosensing of weaning pigs
- Recent legalization of cannabis use: effects on sleep, health, and workplace safety
- Interaction of Cannabis Use and Aging: From Molecule to Mind
- Dietary Geraniol by Oral or Enema Administration Strongly Reduces Dysbiosis and Systemic Inflammation in Dextran Sulfate Sodium-Treated Mice
- Alpha-Phellandrene and Alpha-Phellandrene-Rich Essential Oils: A Systematic Review of Biological Activities, Pharmaceutical and Food Applications
- Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010–2020): A Review
- Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives
- Association Between Use of Marijuana and Male Reproductive Hormones and Semen Quality
- The association between cannabis use and testicular function in men: A systematic review and meta-analysis
- Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies
- Cannabinoids as therapeutic agents in cancer
- Cannabinoids in the treatment of cancer
- Relationship Between Cannabis Use and Erectile Dysfunction: A Systematic Review and Meta-Analysis
- The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis
- Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats
- Corrigendum: Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus
- Hair Regrowth with Cannabidiol (CBD)-rich Hemp Extract
- Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets
- Obesity and cannabis use: results from 2 representative national surveys
- Gender differences of cannabis smoking on serum leptin levels: population-based study
- A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men
- Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9 - Tetrahydrocannabinol
- Cannabinoids and appetite: Food craving and food pleasure
- Oral THC: CBD cannabis extract in main symptoms of Alzheimer disease: agitation and weight loss
- The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders
- Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder
- Lower circulating endocannabinoid levels in children with autism spectrum disorder
- Cannabis and cannabinoid use in autism spectrum disorder: a systematic review
- A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
- Psychoneuroendocrinological links between chronic stress and depression
- Endocannabinoid system: Role in depression, reward and pain control (Review)
- Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
- The highs and the lows: Recreational marijuana laws and mental health treatment
- The Impact of Δ9-THC on the Psychological Symptoms of Anorexia Nervosa
- Are cannabis users less likely to gain weight? Results from a national 3-year prospective study
- A cannabigerol-rich Cannabis sativa extract, devoid of ∆9- tetrahydrocannabinol, elicits hyperphagia in rats
- Recreational cannabis legalization has had limited effects on a wide range of adult psychiatric and psychosocial outcomes
- Medical cannabis laws lower individual market health insurance premiums
- Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients
- Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls
- Testing the Amotivational Syndrome: Marijuana Use Longitudinally Predicts Lower Self-Efficacy Even After Controlling for Demographics, Personality, and Alcohol and Cigarette Use
- Cannabis, motivation, and life satisfaction in an internet sample
- Insomnia treatment: a new multitasking natural compound based on melatonin and cannabis extracts
- Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
- Effects of cannabinoids on adrenaline release from adrenal medullary cells
- Enhancing Endocannabinoid Control of Stress with Cannabidiol
- Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients
- Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder
- The Use of Medicinal Marijuana for Posttraumatic Stress Disorder: A Review of the Current Literature
- Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain
- The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain
- Associations between medical cannabis and prescription opioid use in chronic pain patients
- Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado, 2000-2015
- PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program
- Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies
- Medical cannabis use in the United States: a retrospective database study
- Use of cannabinoids for the treatment of patients with post-traumatic stress disorder
- Cannabis use in active athletes
- The New Runner's High? Examining Relationships Between Cannabis Use and Exercise Behavior in States With Legalized Cannabis
- Recent cannabis use among Veterans in the United States
- A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis
- The cardiac and haemostatic effects of dietary hempseed
- A possible role for the endocannabinoid system in the neurobiology of depression
- Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity
- State Cannabis Legalization and Psychosis-Related Health Care Utilization
- Inhaled D9 -tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression
- Association of cannabis use during pregnancy with severe acute respiratory syndrome coronavirus 2 infection
- Medical cannabis for treatment-resistant combat PTSD
- Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy
- Likelihood of Positive Urine Screens of THC-COOH After Daily Use of Full-Spectrum Hemp Extracts
- Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
- Myrcene—What Are the Potential Health Benefits of This Flavouring and Aroma Agent?
- Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
- The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD
- The Genetic Structure of Marijuana and Hemp
- Cannabis Systematics at the Levels of Family, Genus, and Species
- Use of cannabinoids in cancer care: palliative care
- Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis
- CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
- Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease
- Medical Oncologists’ Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically
- Cannabis in palliative care: current challenges and practical recommendations
- Acidic Cannabinoids Suppress Proinflammatory Cytokine Release by Blocking Store-operated Calcium Entry
- Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol
- Endometriosis: Etiology, pathobiology, and therapeutic prospects
- The Clinical Significance of Endocannabinoids in Endometriosis Pain Management
- Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
- Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
- Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial
- Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination
- Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
- Hormesis and medicine
- Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
- Biphasic Effects of Cannabinoids in Anxiety Responses
- Dose-dependent Effects of Smoked Cannabis on Capsaicin induced Pain and Hyperalgesia in Healthy Volunteers
- Cannabinoids and Epilepsy
- Biphasic effects of THC in memory and cognition
- Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
- The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High?
- Cannabis Use and Blood Pressure Levels
- 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- Cannabinoids for Treating Cardiovascular Disorders
- Endocannabinoids and the Heart
- Anticancer Effect of New Cannabinoids Derived from Tetrahydrocannabinolic Acid
- Phytochemical, proximate composition, amino acid profile and characterization of Marijuana
- Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping in rats
- Cannabinoids Block Cellular Entry of SARS-CoV‐2 and the Emerging Variants
- Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
- Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users
- The therapeutic role of Cannabidiol in mental health: a systematic review
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
- Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
- Transfer of Inhaled Cannabis Into Human Breast Milk
- Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection
- Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model
- Cannabinoid exposure during pregnancy and its impact on immune function
- Birth outcomes associated with cannabis use before and during pregnancy
- The use of cannabis for Hyperemesis Gravidarum (HG)
- Marijuana Use and Maternal Experiences of Severe Nausea During Pregnancy in Hawai‘i
- Endocannabinoid system and pregnancy
- HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation
- A Balanced Approach for Cannabidiol Use in Chronic Pain
- Cannabis and Pain: A Clinical Review
- Anti-Inflammatory Activity in Colon Models Is Derived from D9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts
- Biosynthesis of cannflavins A and B from Cannabis sativa L
- Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9‐tetrahydrocannabinol: a pilot study
- Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs
- Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
- Practical considerations for testing the effects of cannabidiol on human anxiety
- Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants
- Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants
- Letter to the Editor: Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs
- Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model Caenorhabditis elegans
- Safety and tolerability of escalating cannabinoid doses in healthy cats
- Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec
- In Vitro Screening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function
- Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use
- Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
- Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
- Inhibitory effect of cannabichromene
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
- Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases
- Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
- Use of a water-soluble form of cannabinol for the treatment of sleeplessness
- Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome
- Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research
- Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis
- Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy
- Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
- Phytocannabinoids promote viability and functional adipogenesis of bonemarrow-derived mesenchymal stem cells through different molecular targets
- In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
- The Pharmacological Case for Cannabigerol
- Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis derived non-psychotropic cannabinoid
- A cannabigerol-rich Cannabis sativa extract, devoid of ∆-9 tetrahydrocannabinol, elicits hyperphagia in rats
- The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease
- Neurological Aspects of Medical Use of Cannabidiol
- Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series
- Use of a Synthetic Cannabinoid in a Correctional Population for Post-traumatic Stress Disorder Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications
- Chronic Pain Patients’ Perspectives of Medical Cannabis
- The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
- Changing the tone of clinical study design in the cannabis industry
- Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol
- Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
- Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
- A construct divided: prosocial behavior as helping, sharing, and comforting subtypes
- Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment
- Plasma anandamide concentrations are lower in children with autism spectrum disorder
- Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- Bronchodilator Effect of Delta-Tetrahydrocannabinol
- Endocannabinoids and Gonadal Hormones: Bidirectional Interactions in Physiology and Behavior
- The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women
- Cannabis, Cannabinoids, and Sleep: a Review of the Literature
- Review of the neurological benefits of phytocannabinoids
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes
- Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
- Therapeutic Use of Cannabis in Inflammatory Bowel Disease
- Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing
- The role of the endocannabinoid system in female reproductive tissues
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
- A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health
- The Endocannabinoid System of Animals
- Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
- Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
- US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions
- Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects
- Cannabis for the Management of Cancer Symptoms: THC Version 2.0?
- Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
- Medical Cannabis: Effects on Opioid and Benzodiazepine Requirements for Pain Control
- Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study
- Maternal Marijuana Use and Adverse Neonatal Outcomes
- Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes
- Labeling Accuracy of Cannabidiol Extracts Sold Online
- Is time elapsed between cannabis use and sleep start time associated with sleep continuity? An experience sampling method
- Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis
- Interpretation of Workplace Tests for Cannabinoids
- Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program
- Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability
- Immune Responses Regulated by Cannabidiol
- Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer
- Fatty acid amide hydrolase is lower in young cannabis users
- Fatty Acid Amide Hydrolase Controls Mouse Intestinal Motility In Vivo
- Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure
- Effects of Cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without Autism Spectrum Disorder
- Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions
- Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students
- Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- Effect of cannabidiol on cytochrome P-450 isozymes
- Driving Under the Influence of Cannabis An Increasing Public Health Concern
- Differential roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
- Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
- Marijuana Use During Pregnancy and Lactation
- Chemical Characterization and Evaluation of the Antibacterial Activity of Essential Oils from Fibre-Type Cannabis sativa L. (Hemp)
- Cannabis Use in Pregnancy A Tale of 2 Concerns
- Cannabis use by women during pregnancy does not influence infant DNA methylation of the dopamine receptor DRD4
- Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain
- Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
- Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects
- Cannabis and Cannabinoids (PDQ®) - PDQ Cancer Information Summaries
- Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- Cannabinoids and Pain: New Insights From Old Molecules
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
- Cannabinoid receptors and the regulation of immune response
- Cannabinoid Receptor-Specific Mechanisms To Alleviate Pain In Sickle Cell Anemia Via Inhibition Of Mast Cell Activation And Neurogenic Inflammation
- Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ
- Cannabinoid CB1 Receptors Are Expressed by Parietal Cells of the Human Gastric Mucosa
- Cannabidiol Products Are Everywhere, but Should People Be Using Them?
- Cannabidiol in Anxiety and Sleep: A Large Case Series
- Cannabidiol for Viral Diseases: Hype or Hope?
- CANNABIDIOL (CBD) Pre-Review Report
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- Can Cannabis Cure Cancer?
- Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
- Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms
- Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
- Association of Marijuana Laws With Teen Marijuana Use: New Estimates From the Youth Risk Behavior Surveys
- Association of Depression, Anxiety, and Trauma With Cannabis Use During Pregnancy
- Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood A Systematic Review and Meta-analysis
- Association of Cannabinoid Administration With Experimental Pain in Healthy Adults A Systematic Review and Meta-analysis
- Association Between Marijuana Use and Risk of Cancer A Systematic Review and Meta-analysis
- Appraising the “entourage effect”: antitumor action of a pure cannabinoid ver- sus a botanical drug preparation in preclinical models of breast cancer
- A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose, Multiple Dose, and Food Efect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purifed Cannabidiol in Healthy Subjects
- Antioxidant activity and evidence for synergism of Cannabis sativa (L.) essential oil with antimicrobial standards
- Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration
- A systematic review of cannabidiol dosing in clinical populations
- A selective review of medical cannabis in cancer pain management
- A Review of Cannabis in Chronic Kidney Disease Symptom Management
- A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2016-2017
- Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis
- A new ESI-LC_MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
- Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death
- Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson's Disease Patients in Colorado
- Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
- Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- The Endocannabinoid-CB Receptor System: Importance for development and in pediatric disease
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: D9-tetrahydrocannabinol, cannabidiol and D9-tetrahydrocannabivarin
- Regulation of nausea and vomiting by cannabinoids
- Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells
- Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
- Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review)
- Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives
- CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
- Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
- Cannabidiol inhibits angiogenesis by multiple mechanisms
- Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
- Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
- Safety and Toxicology of Cannabinoids
- Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
- Cannabinoid-based Drugs as Anti-Inflammatory Therapeutics
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma–Associated Herpesvirus-Infected Endothelium
- Cannabinoid Type 2 Receptors Mediate a Cell Type Specific Plasticity in the Hippocampus
- The endocannabinoid system in obesity and type 2 diabetes
- Recent advances in cannabinoid receptor agonists and antagonists
- Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood
- Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
- Cannabinoids as therapeutic agents in cancer: current status and future implications
- Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
- Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
- Therapeutic aspects of cannabis and cannabinoids
- Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines
- Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
- Enhanced discriminative stimulus effects of 9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
- Mechanisms of cannabidiol neuroprotection in hypoxiceischemic newborn pigs: Role of 5HT1A and CB2 receptors
- δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
- Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
- Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces
- D9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells
- Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
- Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child
- Update on the Role of Cannabinoid Receptors after Ischemic Stroke
- United States patent application publication for phytocannabinoids in the treatment of cancer
- Understanding Cannabinoids and Epilepsy
- Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
- Treatment of Tourette syndrome with cannabinoids
- Treatment of Crohn's disease with cannabis: an observational study
- Towards the use of cannabinoids as antitumour agents
- Toward Drugs Derived from Cannabis
- Tolerance to the Memory Disruptive Effects of Cannabinoids Involves Adaptation by Hippocampal Neurons
- Tissue Engineering of Cartilage; Can Cannabinoids Help?
- Therapeutical use of the cannabinoids in psychiatry
- Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
- Therapeutic Potential of Cannabinoids in CNS Disease
- Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats
- Therapeutic Benefits of Cannabis: A Patient Survey
- Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis
- The use of cannabinoids as anticancer agents
- The therapeutic potential of novel cannabinoid receptors
- The Therapeutic Potential of Cannabis and Cannabinoids
- The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
- The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
- The Role of Type 2 Cannabinoid Receptor in Bone Metabolism
- The role of the endocannabinoid system in eating disorders: pharmacological implications
- The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice
- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease
- The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
- The potential relevance of the endocannabinoid, 2- arachidonoylglycerol, in diffuse large B-cell lymphoma
- The Pharmacological Basis of Cannabis Therapy for Epilepsy
- The Pharmacologic and Clinical Effects of Medical Cannabis
- The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAa receptor alterations in the human basal ganglia in Huntington's disease
- The orphan receptor GPR55 is a novel cannabinoid receptor
- The Nonpsychoactive Cannabis Constituent Cannabidiol Is a Wake-Inducing Agent
- The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes
- The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects
- The influence of cannabinoids on generic traits of neurodegeneration
- The importance of the ratio of omega-6/omega-3 essential fatty acids
- The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
- The endogenous cannabinoid, anandamide, induces COX-2- dependent cell death in apoptosis-resistant colon cancer cells
- The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2
- The Endogenous Cannabinoid System Stimulates Glucose Uptake in Human Fat Cells via Phosphatidylinositol 3-Kinase and Calcium Dependent Mechanisms
- The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy
- The Endogenous Cannabinoid System and Its Role in Nociceptive Behavior
- The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
- The Endocannabinoid System, Cannabinoids, and Pain
- The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
- The Endocannabinoid System Is Dysregulated in Multiple Sclerosis and in Experimental Autoimmune Encephalomyelitis
- The endocannabinoid system in normal and pathological brain ageing
- The endocannabinoid system in cancer—Potential therapeutic target?
- The endocannabinoid system drives neural progenitor proliferation
- The Endocannabinoid System as an Emerging Target of Pharmacotherapy
- The endocannabinoid system as a target for the treatment of neurodegenerative disease
- The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
- The endocannabinoid system and migraine
- The endocannabinoid system and emotional processing: A pharmacological fMRI study with Δ9-tetrahydrocannabinol
- The endocannabinoid system and cancer: therapeutic implication
- The Endocannabinoid System A New Target for the Regulation of Energy Balance and Metabolism
- The Emerging Role of the Endocannabinoid System in the Sleep-Wake Cycle Modulation
- The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
- The Effects of Marijuana Exposure on Expiratory Airflow A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study
- The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat
- The effects of D9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
- The effects of cannabinoid administration on sleep: a systematic review of human studies
- The Effects of Cannabidiol and Tetrahydrocannabinol on Motion-Induced Emesis in Suncus murinus
- The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
- The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
- The Composition of Hemp Seed Oil and Its Potential as an Important Source of Nutrition
- The Combination of Cannabidiol and D9 -Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
- The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
- The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
- The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
- The case for assessing cannabidiol in epilepsy
- The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection
- The Cannabinoid WIN55212-2 Promotes Neural Repair After Neonatal Hypoxia–Ischemia
- The cannabinoid receptor agonist WIN 55-212-2 facilitates the extinction of contextual fear memory and spatial memory in rats
- The cannabinoid D9 -tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
- The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells
- The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
- The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
- THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms
- Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
- Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
- Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling*
- Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
- Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas
- Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
- Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
- Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
- Survey Results of Pain Treatments in Adults with Cerebral Palsy
- Survey on Cannabis Use in Parkinson’s Disease: Subjective Improvement of Motor Symptoms
- Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid
- Studies Investigating the Mechanisms of the Cardioprotective Effects of Cannabidiol
- Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington’s disease transgenic mice
- Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
- Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
- siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycineinduced cell migration
- Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection
- Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson's Disease Patients in Colorado
- Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
- Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
- Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma
- Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
- Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
- Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
- Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation
- Role of CB2 receptors in social and aggressive behavior in male mice
- Role of cannabinoids in the regulation of bone remodeling
- Review on clinical studies with cannabis and cannabinoids 2010-2014
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- Relationships between eicosanoids and cannabinoids: Are eicosanoids cannabimimetic agents?
- Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy
- Recreational Marijuana Use is Not Associated with Worse Outcomes After Renal Transplantation
- Receptor-dependent and receptor-independent endocannabinoid signaling: A therapeutic target for regulation of cancer growth
- Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
- PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
- Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study
- Protective effects of Δ9-tetrahydrocannabinol against N-methyl-Daspartate-induced AF5 cell death
- Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration
- Prospects for cannabinoid therapies in basal ganglia disorders
- Proof of concept trial of dronabinol in obstructive sleep apnea
- Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
- Proapoptotic effect of endocannabinoids in prostate cancer cells
- Pro-resolution, Protective and Anti-Nocieptive Effects of a Cannabis Extract in the Rat Gastrointestinal Tract
- Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
- Presence of functional cannabinoid receptors in human endocrine pancreas
- Prescribing cannabis for harm reduction
- Preparation and characterization of D9 -tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines
- Prenatal Marijuana Exposure and Neonatal Outcomes in Jamaica: An Ethnographic Stud
- Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder
- Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
- Preclinical Assessment of Novel Therapeutics on the Cough Reflex: Cannabinoid Agonists as Potential Antitussives
- Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2
- Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism
- Potential Effects of Cannabidiol as a Wake-Promoting Agent
- Possible Endocannabinoid Control of Colorectal Cancer Growth
- Plant cannabinoids: a neglected pharmacological treasure trove
- Phytocannabinoids beyond the Cannabis plant – do they exist?
- Phytocannabinoids as novel therapeuticagents in CNS disorders
- Pharmacological actions and therapeutic uses of cannabis and cannabinoids
- Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol
- Peripheral cannabinoid receptor, CB2, regulates bone mass
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- Pathophysiological role of host microbiota in the development of obesity
- Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids
- Oxyradical Stress, Endocannabinoids, and Atherosclerosis
- Overcoming the Bell‐Shaped Dose‐Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
- Opposite Effects of D-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
- Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions
- Novel Study Reports Marijuana Users Have Better Blood Sugar Control
- Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity
- Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
- Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
- No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)
- Neuroprotective Effect of (-)D9 -Tetrahydrocannabinol and Cannabidiol in N-Methyl-D-Aspartate-Induced Retinal Neurotoxicity
- Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
- Neuroprotective antioxidants from marijuana
- Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
- Neuroprotection by D9 -Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
- Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
- Endocannabinoids and traumatic brain injury
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
- Multiple Roles for the Endocannabinoid System During the Earliest Stages of Life: Pre- and Postnatal Development
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- Motor effects of delta 9 THC in cerebellar Lurcher mutant mice
- Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury
- Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
- Modulating the endocannabinoid system in human health and disease: successes and failures
- Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system?
- Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
- Methods of the Pharmacological Imaging of the Cannabinoid System (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition
- Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
- Medical Marijuana: Clearing Away the Smoke
- Medical Marijuana for Cancer
- Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
- Mechanisms of cannabidiol neuroprotection in hypoxic ischemic newborn pigs: Role of 5HT1A and CB2 receptors
- Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver
- Maternal Marijuana Use During Lactation and Infant Development at One Year
- Marijuana: Interaction with the Estrogen Receptor
- Marijuana, Tetrahydrocannabinol, and Pulmonary Antibacterial Defenses
- Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
- Marijuana Use in Potential Liver Transplant Candidates
- Marijuana Use in Epilepsy: The Myth and the Reality
- Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study
- Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis
- Marijuana Rated Most Effective for Treating Fibromyalgia
- Marijuana and chronic obstructive lung disease: a population-based study
- Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
- Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social characteristics, patterns ofcannabis and other drug use of 4117 applicants
- Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation
- Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain
- Keep off the grass? Cannabis, cognition and addiction
- Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood
- Is the cardiovascular system a therapeutic target for cannabidiol?
- Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
- Involvement of the endocannabinoid system in drug addiction
- Involvement of PPARc in the antitumoral action of cannabinoids on hepatocellular carcinoma
- Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat
- Intrahippocampal administration of anandamide increases REM sleep
- Interactions between delta9-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys
- Interactions between cannabidiol and commonly used antiepileptic drugs
- Interaction Between The Protective Effects Of Cannabidiol And Palmitoylethanolamide In Experimental Model Of Multiple Sclerosis In C57bl6 Mice
- Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews
- Integrating cannabis into clinical cancer care
- Injury, Pain, and Prescription Opioid Use Among Former National Football League (NFL) Players
- Inhibition of tumor angiogenesis by cannabinoids
- Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
- Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R( þ )-Methanandamide and JWH-015: Involvement of CB2
- Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor
- Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
- Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1
- Influence of Treatment of Tourette Syndrome with D9-Tetrahydrocannabinol (D9-THC) on Neuropsychological Performance
- The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
- Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent
- Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
- In vitro antibacterial activity of Cannabis sativa leaf extracts to some selective pathogenic bacterial strains
- In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers
- Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists
- Identifying Prenatal Cannabis Exposure and Effects of Concurrent Tobacco Exposure on Neonatal Growth
- Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
- Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
- Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
- Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
- Hypothalamic POMC neurons promote cannabinoid-induced feeding
- Hyperalgesia by low doses of the local anesthetic lidocaine involves cannabinoid signaling: An fMRI study in mice
- HU211, a Novel Noncompetitive NMethylDAspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the Rat
- Histone Modifications Are Associated with Delta (9)-tetrahydrocannabinol-Mediated Alterations in Antigen-Specific T Cell Responses
- Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle
- High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma
- Hemp Oil Ingestion Causes Positive Urine Tests for Ag-Tetrahydrocannabinol Carboxylic Acid
- Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity
- Gynecomastia and cannabis smoking: A nonassociation among US Army soldiers
- Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors
- GPR55: A therapeutic target for Parkinson's disease?
- Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism
- Future of Cannabis and Cannabinoids in Therapeutics
- Functional Role for Cannabinoids in Respiratory Stability During Sleep
- Five-year Follow-up of Rural Jamaican Children whose Mothers used Marijuana during Pregnancy
- Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling
- Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism
- Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for ∆9 -Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice
- Extraction of cannabinoids from cannabis sativa L plant and its potential antimicrobial activity’
- Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
- Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation
- Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma
- Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
- Evidence that the plant cannabinoid cannabigerol is a highly potent a2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
- Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid
- Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
- Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
- Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines
- Estrogen Receptor Beta and 2-arachidonoylglycerol Mediate the Suppressive Effects of Estradiol on Frequency of Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons of Metestrous Mice: An Acute Slice Electrophysiological Study
- Estradiol Decreases Cortical Reactive Astrogliosis after Brain Injury by a Mechanism Involving Cannabinoid Receptors
- Essential oils of different cultivars of Cannabis sativa L. and their antimicrobial activity
- Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy
- Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules
- Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice
- Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol
- Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia
- Endogenous cannabinoid system as a modulator of food intake
- Endocannabinoids: A Promising Impact for Traumatic Brain Injury
- Endocannabinoids, feeding and suckling – from our perspective
- Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage
- Endocannabinoids in the Retina: From Marijuana to Neuroprotection
- Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine
- Endocannabinoids in Liver Disease
- Endocannabinoids in endocrine and related tumours
- Endocannabinoids as Guardians of Metastasis
- Endocannabinoids and the haematological system
- Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
- Endocannabinoids and energy homeostasis: An update
- Endocannabinoids and Cancer
- Endocannabinoid System in First Trimester Placenta: Low FAAH and High CB1 Expression Characterize Spontaneous Miscarriage
- Endocannabinoid System as Novel Therapeutic Target for Autism Treatment
- Endocannabinoid signalling and the deteriorating brain
- Endocannabinoid Signaling Regulates Sleep Stability
- Endocannabinoid signaling in neurotoxicity and neuroprotection
- Endocannabinoid concentrations in hair are associated with PTSD symptom severity
- Endocannabinoid CB1 receptor-mediated rises in Ca2+ and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus
- Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
- Elevated Brain Cannabinoid CB1 Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study
- Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
- Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
- Effects of Marijuana Smoking on the Lung
- Effects of deleting cannabinoid receptor-2 on mechanical and material properties of cortical and trabecular bone
- Effects of cannabis on cognitive function in patients with multiple sclerosis
- Effects of Cannabinoids on LPS-Stimulated Inflammatory Mediator Release From Macrophages: Involvement of Eicosanoids
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia
- Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow
- Effects of anandamide in migraine: data from an animal model
- Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study
- Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana
- Effect of D-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults
- Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism
- Early phytocannabinoid chemistry to endocannabinoids and beyond
- Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet
- Drug Reinforcement in a Rat Model of Attention Deficit/Hyperactivity Disorder – The Spontaneously Hypertensive Rat (SHR)
- Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
- Dose-Related Differences in the Regional Pattern of Cannabinoid Receptor Adaptation and in Vivo Tolerance Development to Δ9- Tetrahydrocannabinol
- Does smoking marijuana increase the risk of chronic obstructive pulmonary disease?
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
- Distinct Effects of 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- Differential role of cannabinoids in the pathogenesis of skin cancer
- Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases
- Delta-9-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression in Vitro and in Vivo
- Delta-9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria
- Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
- Deficient Social and Play Behavior in Juvenile and Adult Rats after Neonatal Cortical Lesion: Effects of Chronic Pubertal Cannabinoid Treatment
- D9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity
- D9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells
- D9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
- Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries
- COX-2 and PPAR-g Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
- Cortical GAD67 deficiency results in lower cannabinoid 1 receptor mRNA expression: Implications for schizophrenia
- Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders
- Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache
- Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity
- Combined treatment with morphine and Δ9 -tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal
- Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions
- Clinical Implications for Cannabinoid Use in the Rheumatic Diseases: Potential for Help or Harm?
- Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
- Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
- Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions?
- Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
- Chronic administration of cannabidiol to healthy volunteers and epileptic patients
- Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
- Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications
- Chemical constituents of marijuana: The complex mixture of natural cannabinoids
- Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
- Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
- Changes of endocannabinoid plasma levels following type I trauma: A prospective pilot study
- Ceramide: a new second messenger of cannabinoid action
- CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience
- CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
- CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice
- Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
- Cannabinoids, cannabinoids and tinnitus
- Cannabis, a complex plant: different compounds and different effects on individuals
- Cannabis use in sickle cell disease: a questionnaire study
- Cannabis Use in HIV for Pain and Other Medical Symptoms
- Cannabis use amongst patients with inflammatory bowel disease
- Cannabis sativa: The Plant of the Thousand and One Molecules
- Cannabis Responsive Head Injury Induced Mutiple Disabilities: A Case Report
- Cannabis Induces a Clinical Response in Patients With Crohn’s Disease: A Prospective Placebo-Controlled Study
- Cannabis in the Management and Treatment of Seizures and Epliepsy: A Scientfic Review
- Cannabis in the Arm: What Can we Learn from Intravenous Cannabinoid Studies?
- Cannabis in Cancer Care
- Cannabis improves symptoms of ADHD
- Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
- Cannabis Finds Its Way into Treatment of Crohn’s Disease
- Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation
- Cannabis as a substitute for prescription drugs – a cross-sectional study
- Cannabis as a substitute for alcohol and other drugs
- Cannabis and its effect on anesthesia
- Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
- Cannabis and Eicosanoids: A Review of Molecular Pharmacology
- Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
- Cannabis and Cannabinoids (PDQ®)
- Cannabis and Breastfeeding
- Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials
- Cannabis Alleviates Symptoms Of Crohn’s Disease
- Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation
- Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival
- Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury
- Cannabinoids: potential antitumoral agents?
- Cannabinoids: A new hope for breast cancer therapy?
- Cannabinoids, inflammation, and fibrosis
- Cannabinoids, Immune System and Cytokine Network
- Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
- Cannabinoids, Endocannabinoids and Cancer
- Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells
- Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells
- Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
- Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
- Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
- Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
- Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing
- Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
- Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
- Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
- Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis
- Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression
- Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes
- Cannabinoids in the Treatment of Epilepsy
- Cannabinoids in the management of spasticity associated with multiple sclerosis
- Cannabinoids in the management of difficult to treat pain
- Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
- Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
- Cannabinoids in Models of Chronic Inflammatory Conditions
- Cannabinoids in health and disease
- Cannabinoids in experimental stroke: a systematic review and meta-analysis
- Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential
- Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
- Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
- Cannabinoids for Tourette’s Syndrome (Review)
- Cannabinoids for the treatment of dementia
- Cannabinoids for pediatric epilepsy? Up in smoke or real science?
- Cannabinoids for Neuropathic Pain
- Cannabinoids for Cancer Treatment: Progress and Promise
- Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain
- Cannabinoids control spasticity and tremor in a multiple sclerosis model
- Cannabinoids as potential new therapy for the treatment of gliomas
- Cannabinoids as novel anti-inflammatory drugs
- Cannabinoids as Antioxidants and Neuroprotectants
- Cannabinoids and the skeleton: From marijuana to reversal of bone loss
- Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
- Cannabinoids and the gastrointestinal tract
- Cannabinoids and the immune system
- Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
- Cannabinoids and neuroprotection in basal ganglia disorders
- Cannabinoids and multiple sclerosis
- Cannabinoids and glaucoma
- Cannabinoids and Cystic Fibrosis: A Novel Approach to Etiology and Therapy
- Cannabinoids and ceramide: Two lipids acting hand-by-hand
- Cannabinoids and cancer: pros and cons of an antitumour strategy
- Cannabinoids and Cancer
- Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro
- Cannabinoids Ameliorate Pain and Reduce Disease Pathology in Cerulein-Induced Acute Pancreatitis
- Cannabinoid–Opioid Interaction in Chronic Pain
- Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
- Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat–an animal model of attention deficit hyperactivity disorder
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
- Cannabinoid-associated cell death mechanisms in tumor models
- Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1b induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes
- Cannabinoid system and cyclooxygenases inhibitors
- Cannabinoid Regulation of Acute and Anticipatory Nausea
- Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
- Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
- Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
- Cannabinoid receptors as novel targets for the treatment of melanoma
- Cannabinoid receptors and their ligands
- Cannabinoid receptors and the regulation of bone mass
- Cannabinoid receptors and pain
- Cannabinoid Receptors and Endocannabinoids: Evidence for New Players
- Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
- Cannabinoid Receptor-Mediated Apoptosis Induced by R(+)- Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma
- Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
- Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders
- Cannabinoid receptor ligands as potential anticancer agents – high hopes for new therapies?
- Cannabinoid receptor CB1-like and glutamic acid decarboxylase-like immunoreactivities in the brain of Xenopus laevis
- Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
- Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer
- Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest
- Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells
- Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
- Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α-Mediated Ceramide De novo Synthesis in Colon Cancer Cells
- Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+ T Cells
- Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation
- Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
- Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma
- Cannabinoid pharmacology: the first 66 years
- Cannabinoid Modulation of Neuroinflammatory Disorders
- Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins
- Cannabinoid facilitation of fear extinction memory recall in humans
- Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety
- Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint
- Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- Cannabinoid CB2 receptors in human brain inflammation
- Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
- Cannabinoid CB2 Receptor Activation Attenuates Motor and Autonomic Function Deficits in a Mouse Model of Spinal Cord Injury
- Cannabinoid CB1 receptor binding and acetylcholinesterase inhibitory activity of Sceletium tortuosum L.
- Cannabinoid agonist rescues learning and memory after a traumatic brain injury
- Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
- Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism
- Cannabidivarin is anticonvulsant in mouse and rat
- Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression
- Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
- Cannabidiol: Promise and Pitfalls
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- Cannabidiol, a nonpsychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
- Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87- MG and T98G Glioma Cells through a Multitarget Effect
- Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
- Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
- Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
- Cannabidiol Reverses MK-801-Induced Disruption of Prepulse Inhibition in Mice
- Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine
- Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
- Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
- Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
- Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
- Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
- Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
- Cannabidiol Inhibits Cancer Cell Invasion Via Upregulation Of Tissue Inhibitor Of Matrix Metalloproteinases-1
- Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
- Cannabidiol in Humans—The Quest for Therapeutic Targets
- Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series
- Cannabidiol Attenuates the Appetitive Effects of D9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- Cannabidiol as potential anticancer drug
- Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress
- Cannabidiol as a potential treatment for psychosis
- Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
- Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice
- Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease
- Cannabidiol and (-)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
- Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
- Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
- Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A
- Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
- Blood pressure regulation by endocannabinoids and their receptors
- Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus: Site and Mechanism of Action
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
- Associations between Adolescent Cannabis Use and Neuropsychological Decline: A Longitudinal Co-Twin Control Study
- Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder
- Association of Herbal Cannabis Use With Negative Psychosocial Parameters in Patients With Fibromyalgia
- Association Between Marijuana Exposure and Pulmonary Function Over 20 Years
- Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects
- Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review
- Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
- Around‐the‐Clock Oral THC Effects on Sleep in Male Chronic Daily Cannabis Smokers
- Antitumorigenic Effects of Cannabinoids beyond Apoptosis
- Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
- Antimicrobial Activity of Cannabis sativa L.
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L
- Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa
- Anticancer mechanisms of cannabinoids
- Antibacterial Cannabinoids from Cannabis sativa: A Structure-Activity Study
- Antibacterial activity of Δ9-tetrahydrocannabinol and cannabidiol
- Antiangiogenic Activity of the Endocannabinoid Anandamide: Correlation to its Tumor-Suppressor Efficacy
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
- Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells
- Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
- Anti-inflammatory potential of CB1-mediated CAMP elevation in mast cells
- Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells
- Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
- Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
- Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
- An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
- An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity
- An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease
- An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
- An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
- Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid
- Alterations in the endocannabinoid system in the rat valproic acid model of autism
- Allosteric Modulation of the Cannabinoid CB1 Receptor
- Agonistic Properties of Cannabidiol at 5-HT1a Receptors
- Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats
- Administration of URB597, Oleoylethanolamide or Palmitoylethanolamide Increases Waking and Dopamine in Rats
- Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI
- Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
- Activity of cannabis in relation to its delta'-trans-tetrahydro-cannabinol content
- Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures
- Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus
- Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury
- Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
- Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation
- Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells
- Activation of Cannabinoid CB2 Receptor - Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
- Action of Cannabidiol on the Anxiety and Other Effects Produced by D9-THC in Normal Subjects
- Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
- Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients
- Stable dose cannabinoid medicine GW
- Role of cannabinoids in pain management
- A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
- Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence
- The case for medical marijuana in epilepsy
- On the application of cannabis in pediatrics and epileptology
- Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se
- Cannabinoids with children
- Cannabis use, attitudes, and legal status in the U.S.: A review
- Cannabinoids for treatment of chronic non-cancer pain
- Amyloid-beta inhibits E-S Potentiation through suppression of cannabinoid receptor 1 dependent synaptic disinhibition
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
- A pilot clinical study of D9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
- A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
- A Molecular Link Between the Active Component of Marijuana and Alzheimer's Disease Pathology
- A Longitudinal Study of Prenatal Marijuana Use Effects on Sleep and Arousal at Age 3 Years
- A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
- A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches
- A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells
- 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid
- (−)δ9 THC as an hypnotic
Popups
Popup Themes
- Content Only - For use with page builders or block editor
- Floating Bar - Soft Blue
- Framed Border
- Cutting Edge
- Hello Box
- Enterprise Blue
- Light Box
- Default Theme
Dashboard Collection
Condition
- Acute Respiratory Distress Syndrome (ARDS)
- Addiction
- Aging
- Allergies
- Alzheimer's Dementia
- Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's)
- Anorexia Nervosa
- Antibacterial
- Antifungal
- Antimicrobial
- Antioxidant
- Antiviral
- Anxiety
- Appetite
- Arthritis
- Asthma
- Attention Deficit Hyperactivity Disorder (ADHD)
- Autism Spectrum Disorder (ASD)
- Autoimmune Diseases
- Autoimmune Hepatitis
- Batten Disease
- Behavior
- Bipolar Disorder/s
- Blood
- Blood Clots
- Blood Pressure
- Bone
- Bone Marrow Transplant
- Brain Function
- Breast Cancer
- Cancer
- Cancer>Colorectal Cancer
- Cancer>Liver cancer
- Cancer>Oral Cancer
- Cancer>Ovarian Cancer
- Cancer>Pancreatic Cancer
- Cancer>Prostate Cancer
- Cannabinoid Hyperemesis Syndrome (CHS)
- Cannabis Use Disorder
- Cardiovascular
- Cellular Function
- Cerebral Palsy
- Cognition
- Colon Cancer
- Concussion
- Covid-19
- Crohn's Disease
- Dementia
- Depression
- Developmental Impact
- Diabetes
- Disruptive Behavior Disorders
- Down's Syndrome
- Drug Interactions
- Dysmenorrhoea
- Emesis
- Encephalopathy
- Endocannabinoid System (ECS)
- Endocrine System
- Endometriosis
- Epilepsy
- Erectile Dysfunction
- Exercise Recovery
- Eye Function
- Fatigue
- Fibromyalgia
- Fibrosis
- Gastrointestinal Disease
- Gastrointestinal Function
- General Information
- Glaucoma
- Glioblastoma
- Glioma
- Gulf War Illness
- Hair Health
- Headache
- Heart Attack (Myocardial Infarction)
- Hepatitis C
- HIV
- Human Behavior
- Huntington's Disease
- Hyperinsulinemia
- Hypothyroidism
- Immune Function
- Infant Development
- Inflammation
- Inflammatory Bowel Disease (IBD)
- Insomnia
- Intellectual Disability
- Invertebral Disc (IVD) Degeneration
- Irritable Bowel Syndrome (IBS)
- Ischemia
- Kidney
- Krabbe Disease
- Leukemia
- Liver
- Lung Cancer
- Lungs
- Lupus
- Lyme Disease
- Memory
- Menopause
- Menstrual Cycle
- Mental Disorders
- Metabolism
- Migraine
- Mitochondria
- MTHFR Gene Mutation
- Multiple Sclerosis
- Multiple Sclerosis>Demyelination
- Muscular
- Nausea
- Nervous System
- Neuro-protective/Neuro-generative
- Neuroinflammation
- Neuropathy
- Non-Epileptic Seizures
- Non-Hodgkin's Lymphoma
- Nutrition
- Obesity
- Obsessive Compulsive Disorder (OCD)
- Ocular Health
- Oral Health
- Organ Transplants
- Osteoarthritis
- Osteoporosis
- Pain
- Palliative Care
- Pancreatitis
- Parkinson's Disease
- Pets
- Pharmacogenetics
- Pharmacokinetics
- Pharmacology
- Playing-Related Musculoskeletal Disorders (PRMDs)
- Post Traumatic Stress Disorder (PTSD)
- Post-Concussion Syndrome
- Postoperative Pain
- Potential of whole plant vs. single compound model
- Pregnancy
- Prostate Cancer
- Psoriasis
- Psychosis
- Pulmonary Embolism
- Pulmonary Function
- Reproductive System
- Respiratory Disease
- Rett Syndrome
- Safety
- Schizophrenia
- Sexual Function
- Sickle-cell Disease
- Skeletal System
- Skin
- Sleep
- Spasticity
- Spinal cord injury
- Sports
- Stress
- Stroke
- Suicidal Ideation
- Surgery
- Temporomandibular Disorders (TMDs)
- Tinnitus
- Tourette's syndrome
- Traumatic Brain Injury (TBI)
- Tuberous sclerosis
- Ulcerative Colitis
- Wellness
- Wound Healing
Research Keyword
- -linolenic acid
- -sitosterol
- ∆9-tetrahydrocannabinol (THC)
- ∆9-tetrahydrocannabinolic acid (THCA)
- ∆9-tetrahydrocannabivarin (THCV)
- 2-Arachidonoylglycerol (2-AG)
- 2-methyl-2'-F-anandamide
- 3 H-Naltrindole binding
- 5-HT1A receptor
- 5-hydroxytryptamine (5-HT)
- 6-hydroxydopamine
- 8-OH-DPAT
- a/b-hydrolase domain.
- a2-adrenoceptor
- A549
- ABCA6
- abdominal obesity
- ABHD12
- ABHD6
- Abn-CBD
- Abnormal cannabidiol receptor
- Absorption
- Accuracy
- acetic-acid
- acetylcholine
- acetylcholine release
- Acetylcholinesterase
- acne vulgaris
- ACTH
- Actigraphy
- ACTOne
- Acute lymphoblastic leukemia
- acute nausea
- acute pancreatitis
- Adaptor Proteins
- addiction
- addictive behaviors
- Adenocarcinoma cells
- Adenosine
- adenylate cyclase inhibition
- Adipocytes
- adipose-derived mesenchymal stem cells
- adolescence
- adrenal gland
- adrenaline release
- adriamycin
- Adult
- Adverse Side Effect
- AEA
- AEDs
- aggression
- Aging
- agitation
- agonist
- AIDS
- ajulemic acid
- alcohol-drinking behavior
- alcoholism
- alkaloid
- ALL
- Allelic Group
- allodynia
- Allosteric modulator
- alpha-MSH/metabolism
- Alpha-phellandrene
- Alternate matrix
- Alzheimer’s disease
- AM1241
- AM404
- AM630
- Amid hydrolase
- aminoalkylindole
- AML
- amotivational syndrome
- AMPK
- Amygdala
- amyloid-β
- amyotrophic lateral sclerosis
- analgesia
- analgesics
- Anandamide (AEA)
- androgen
- Androgen antagonists
- angiogenesis
- Anibacterial activity
- animal model
- Animal/s
- anorexia nervosa
- antagonist
- anti-angiogenic
- anti-cancer
- anti-excitotoxicity
- Anti-inflammatory
- Anti-metastasis
- anti-obesity drugs
- Anti‐Nociceptive
- Antibacterial Activity
- anticipatory nausea
- anticonvulsant
- Antidepressant
- Antiepileptic drugs
- antifibrotic
- Antifungal activity
- Antimicrobial
- Antineoplastic agents
- antinociception
- Antioxidant
- Antipsychotic
- antiseizure
- antitumoral
- antitumoral drug
- antiviral
- anxiety
- Anxiety disorders
- Anxiolytics
- apnea
- apoptosis
- appetite
- arachidonic acid
- arginase
- Arousal/drug effects
- arrhythmias
- asthma
- Astrocytes
- astrogliosis
- Ataractics: marijuana
- atherogenesis
- ATP synthase
- attention bias
- Attention deficit hyperactivity disorder (ADHD)
- Autism Spectrum Disorder (ASD)
- Autoimmune Diseases/drug therapy
- autoimmunity
- autoimpairment
- autophagy
- autoprotection
- autoradiography
- Aversion
- B cells
- b-amyloid
- BAD
- Basal ganglia
- Base Sequence
- basket cells
- BBB integrity
- Bedrocan
- Behavior
- Behavioral disturbances
- Benzodiazepines
- Beta cell
- beta-Endorphin/metabolism
- BeWo and Jar cells
- Bhang
- bile acids
- Binding Sites
- binge eating
- biomarkers
- Biotransformation
- biphasic effects
- Blastocyst
- Blood oxygen
- blood-brain barrier
- BMI
- bone
- bone cancer
- bone formation
- Bone marrow derived mesenchymal stem cells
- bone mass
- bone mineral density
- bone remodeling
- bone resorption
- bortezomib
- botanical drug preparation
- bowel cancer
- brain
- brain development
- brain imaging
- brain tumor
- breast cancer
- Breast Cancer Resistance Protein (BCRP)
- breast carcinoma
- Breast neoplasms
- breastfeeding
- breathlessness
- bronchodilator
- browning of adipose tissue
- BTBR T+tf/J mice
- bulimia nervosa
- C57BL/6J mouse
- Ca2
- Caco-2 cells
- calcium
- cam
- cAMP
- cancer
- Cancer cell growth
- cancer cells
- canine
- Cannabaceae
- Cannabichromene (CBC)
- Cannabidiol (CBD)
- Cannabidiolic acid (CBDA)
- Cannabidivarin (CBDV)
- Cannabigerol (CBG)
- Cannabigerolic acid (CBGA)
- cannabinoid quinone
- Cannabinoid receptor 1 (CB1)
- Cannabinoid receptor 2 (CB2)
- Cannabinoid receptor agonist/s
- Cannabinoid receptor antagonist/s
- Cannabinoid receptor/s
- cannabinoid therapy
- cannabinoid transporters
- Cannabinoid-dopamine
- Cannabinoid/s
- Cannabinol (CBN)
- cannabinomimetic compounds
- Cannabis
- Cannabis constituents
- Cannabis efficacy
- Cannabis policy
- Cannabis safety
- cannabis sativa
- Cannabis sativa L. Clone 202
- Cannabis sativa L. roots
- Cannabis sativa Seeds
- cannabis treatment
- Cannabis Use Disorder (CUD)
- capsazepine
- carbon dioxide
- Carboxyhemoglobin
- cardiac
- Cardiac contractility
- cardiometabolic risk
- cardiovascular
- cartilage
- caryophyllene
- Case Report
- Caspase Inhibitors
- cat
- cataleptic activity
- caudate nucleus
- causalgia
- CB1 m-opioid receptors
- CB1 receptor agonist/s
- CB1 receptor antagonist/s
- CB2 receptor agonist/s
- CB2 receptor antagonist/s
- CB2KO mice
- CBD oil
- CBD receptor binding
- CBD-enriched medical cannabis
- CBI
- CCND1
- CD4 T-cell
- cell adhesion
- Cell cycle arrest
- Cell Line
- cell proliferation
- Cell signaling
- cell-free conversion
- Cells
- Cellular migration
- cellulose
- Ceramide
- Cerebellum
- cerebral ischemia
- cerebral palsy
- Charlotte’s Web.
- Chemokines
- chemoprevention
- chemotherapeutic
- chemotherapy-induced neuropathic pain
- Childhood
- children
- cholecystokinin
- chronic abdominal pain
- chronic bronchitis
- Chronic disease
- chronic neuroinflammation
- chronic obstructive lung disease
- chronic pain
- CIPN
- client communication
- clinical applications
- clinical trial/s
- Clobazam
- clonidine
- closed head injury
- CNS
- Cocaine
- cognition
- Cognitive effects
- Cohort studies
- colitis
- Colon cancer
- Combinational therapy
- complimentary alternative medicine
- Computer-Assisted
- concussions
- conditioned disgust
- conditioned gaping
- Conditioned place preference
- Confocal microscopy
- COPD
- cortex
- Corticosterone
- cough
- covid
- COX
- CP55940
- Crohn’s Disease
- cross-lagged panel modeling
- Crude extracts
- Cultured
- cyclooxygenase
- cyclooxygenase inhibition
- cyclooxygenase-2
- CYP2C19
- CYP3A4
- cystic fibrosis
- cystine/glutamate transporter
- Cytochrome P450
- Cytokines
- D1 dopamine receptors
- D2 dopamine receptors
- daily cannabis smokers
- DB/A2 mice
- degredation
- delayed-nonmatch-to-sample
- delta power spectra
- dementia
- demyelination
- dependence
- depression
- Desipramine
- development
- dexanabinol
- dexmedetomidine
- dextran sulfate sodium (DSS)-induced colitis
- Diabetes
- diacylglycerol lipase
- Dietary recommendations
- differentiation
- diffuse axonal injury
- dimethylheptyl-cannabidiol (CBD-DMH)
- dimethylsulfoxide
- Dinitrovenzene suphonic acid
- disc degeneration
- Disease
- Disease Models
- Disease Progression
- Distribution
- DLBCL
- DMSO
- DNA damage
- DNA Primers
- Docosahexaenoic acid
- dog
- Dopamine
- Dopamine receptor
- Dorsal hippocampus
- Dose-Response Relationship
- Double-Blind Method
- Down-Regulation
- Downstream events
- Dravet syndrome
- driving
- Dronabinol
- Drug
- drug addiction
- drug combination
- drug delivery
- Drug dependence
- drug discovery
- drug discrimination
- drug of abuse
- Drug overdose
- drug resistance
- drug schedule
- drug self-administration
- drug test
- drug treatment
- drug use
- DSI
- dual-specificity phosphatases
- dysbiosis
- dystonia
- EAE
- early infantile autism
- Effectiveness
- efficacy
- effort
- EGFR
- eicosanoid biosynthesis
- eicosanoids
- Eicosapentaenoic acid
- electroencephalogram
- Electrophoresis
- Electrophysiology
- electroretinographic waves
- ELISA
- elmiric acid
- emesis
- Emotional processing
- encephalopathy
- endocannabinoid receptors
- endocannabinoid signaling
- endocannabinoid system
- endocannabinoid-based therapy
- Endocannabinoid/s
- endocannabinoidome
- endocrine
- Endogenous cannabinoid agonist
- endoplasmic reticulum stress
- endothelium
- endotoxin
- energy balance
- Energy metabolism
- enteric nervous system
- entourage effect
- Enzyme system
- Enzyme-Linked Immunosorbent Assay
- Epidemiology
- Epigenetics
- Epilepsy
- epileptiform activity
- ErbB-2
- ERK
- essential fatty acid
- essential oil composition
- essential oils
- estradiol
- estrogen deficiency
- estrogen receptor beta
- Estrogen/metabolism
- ethics
- excitotoxicity
- Excretion
- executive functions
- exercise
- experimental allergic encephalomyelitis
- experimental autoimmune encephalomyelitis
- experimental lung metastasis
- experimental metastasis
- experimental pain
- experimental therapeutics
- Extinction
- extracellular matrix
- Extracellular signal–regulated kinase (ERK)
- extract
- eye
- FAAH
- FAAH and MAGL enzymes
- Facial Expression
- failure-to-thrive
- fast cyclic voltammetry
- fatty acid amide hydrolase (FAAH)
- fatty acid binding protein (FABP)
- fatty acids
- fatty liver
- FCS
- Fear conditioning
- fear extinction
- fear memory
- feeding
- Female
- fetal alcohol
- fetal calf serum
- FIAF
- fibers
- Fibroblast-like synoviocyte
- fibromyalgia
- flavonoids
- fluorouracil
- Fluoxetine
- fMRI
- focal N-methyl-D-aspartate
- food intake
- food preservatives
- food-borne pathogens
- forced expiratory volume
- Forced swim test
- forced vital capacity
- Formalin test
- Fragile X Syndrome
- Free radicals
- Frontal lobe
- FTO (Fat Mass and Obesity-Associated) Gene
- Functional effects
- functional food
- FXR
- G protein-coupled receptor/s
- G Proteins
- G-CSF
- GABA
- GABAAa2
- GABAAg2
- galenical preparation
- Galvanic skin response
- gaping
- Gastric cancer
- gastric damage
- gastric fluid
- Gastric Mucosa
- gastrointestinal motility
- gastrointestinal tract
- gene expression
- genes
- Genetic
- Genetic patterns
- genioglossus
- geraniol
- Ghrelin
- Ghrelin receptor
- glaucoma
- glia
- glial regulation
- glioblastoma
- glioblastoma multiforme
- Glioma cell/s
- Gliomas
- globus pallidus
- Glucagon
- Glucose
- glutamate
- glutamate receptor
- Glutamate toxicity
- Glutamic acid decarboxylase
- glutathione
- Glycerides
- glycerol
- GnRH neuron
- GPCR
- GPR18
- GPR55
- graft
- Growth hormone secretagogue receptor knockout
- GTPgS assay
- Gut microbiota
- gynecology
- Gyrus Cinguli
- H-DAMGO binding
- haematopoesis
- Hair
- hair regrowth
- Harm Reduction
- HCV
- head trauma
- headache
- health
- Health Services Accessibility
- Healthy volunteers
- Helix-loop-helix
- Hemodynamics
- hemp
- Hemp (Cannabis sativa L.) seed oil
- Hemp oil
- hepatic encephalopathy
- hepatitis
- hepatitis B virus
- hepatocellular carcinoma
- HepG2
- herbal cannabis
- herbal medicine
- herbal synergy
- Heroin
- Hind limb suspension
- hippocampal cell death
- hippocampal neural progenitor
- hippocampus
- Histone methylation
- History
- HIV
- hormones
- HPA-axis
- Ht1a
- HU-211
- HU-308
- HU-320
- human
- human brain
- human cancer cells
- human colon cell line
- human immune system
- Human liver microsomes
- Human placenta
- Huntington’s disease
- HUVEC
- Hyperalgesia
- Hyperglycaemia
- hyperphagia
- Hypertension
- Hypnotics
- hypothalamus
- hypothermia
- hypoxia-ischemia
- hypoxic-ischemic encephalopathy
- ICAM-1
- Id-1
- Id-2
- idiopathic bowel disease
- IL-1ra
- Illicit Drug
- Image Processing
- imaging
- immune cells
- Immune response
- immune suppression
- Immune System
- Immunity
- immunohistochemistry
- Immunosuppression
- implantation
- in situ hybridization
- In Vitro Techniques
- Inbred C57BL
- Inbred strain/s
- individual sensitivity to cannabis
- Infant development
- Infection
- Infiltrates
- inflammation
- Inflammatory bowel disease (IBD)
- inflammatory pain
- inhibition
- inhibitor
- Inhibitor of Differentiation Protein 1/genetics
- Innate immunity
- insecticides
- insomnia
- insulin
- Insulin resistance
- insulin sensitivity
- intellectual disability
- Interleukin-6
- interneurons
- intestinal anti-inflammatory
- intestinal permeability
- Intractable
- Intractable epilepsy
- Intravenous
- invasion
- inverse agonist
- investigational therapies
- ion channels
- IOP
- IQ
- Irritable bowel syndrome (IBS)
- ischemia-reperfusion
- ischemic brain injury
- ischemic myocardium
- ischemic stroke
- Islets of Langerhans
- isobologram
- isothiocyanates
- JWH-015
- JWH-018
- JWH133
- Kaposi sarcoma
- Kaposi sarcoma–associated herpesvirus
- Kensington Standardized Behavioural Assessment
- Keratinocyte proliferation
- kinetics
- Knee
- Knockout
- kougoed
- L-DOPA
- label accuracy
- Lactation
- lactobacillus
- LDT
- learning and memory
- legal status
- Legislation
- lennox-gastaut
- leptin
- Leukemia
- leukotrienes
- levonantradol
- Lidocaine
- life satisfaction
- lignans
- lignin
- limonene
- linalool
- linoleic acid
- Lipid
- lipid trafficking
- lipooxygenase
- lipopolysaccharide induced edema
- Lipoprotein Lipase
- lipoxygenase
- Liver
- liver disease
- liver enzymes
- Locomotor activity
- longitudinal
- LPS
- Lung
- lung cancer
- lung function
- Lung metastasis
- Lurcher mutant mice
- lymphatic transport
- Lymphocyte/s
- lymphoma
- macromolecule clearance
- Macrophage/s
- MAGL
- Magnetic Resonance Imaging
- major depression
- Male
- male reproductive health
- mania
- mantle cell lymphoma
- MAPK/ERK
- maprotiline
- Marble burying test
- marijuana
- marijuana smoking
- Mass spectrometry
- Mast cell/s
- maternal deprivation
- Matrigel cell invasion
- Matrix Metalloproteinase 2
- Matrix metalloproteinase 23
- Matrix Metalloproteinase 9
- Maximal electroshock
- mCPP
- mechanical properties
- mechanical sensitivity
- mechanisms
- MECP2
- medical cannabis
- Medical marijuana
- medical uses
- Medically refractory epilepsy
- Medically refractory seizures
- medicinal
- medicinal cannabis
- medicinal plants
- Melanoma
- melatonin
- MEM
- Memory reconsolidation
- Mental disorders
- mesenchymal stem cells
- meta-analysis
- Metabolic defects
- metabolic disorders
- Metabolic inflammation
- Metabolic Syndrome
- Metabolism
- Metabotropic Glutamate
- Metallothionein
- metastasis
- metastasization
- methanandamide
- Methanol Extract
- methicillin-resistant Staphylococcus aureus (MRSA)
- Metyrapone
- mGluR
- Mice
- microdialysis
- microencapsulation
- Microglia
- microglial activation
- Microsomes
- midazolam
- Middle Aged
- Migraine
- migration
- minimal essential medium
- Minimum Inhibit Concentration
- minocycline
- Miscarriage
- Mitochondria
- mitochondrial dysfunction
- Mitochondrial Proteins
- mobility
- Models
- molecular dynamics
- monoacylglycerol lipase
- Monoamines
- Monocyte
- monocyte-like cells
- morphine place preference
- Mortality
- motility
- motion sickness
- motivation
- Motor abilities
- motor fluctuation
- Motor function
- Motor learning
- Motor neuron disease
- Mouse
- mouse behavior
- mouse brain
- mouse model
- mouse vas deferens
- Mouth Region
- MPTP
- multiple myeloma
- Multiple sclerosis (MS)
- Multiple sclerosis Inflammation
- Multiple sclerosis spasticity
- Murine colitis
- murine collagen-induced arthritis
- muscle spasms
- mutant huntington
- Mutation
- myeloid-derived suppressor cells
- myocardial infarction
- Myocardial Ischaemia
- myrcene
- N-acyl phosphatidylethanolamine phospholipase D
- N-arachidonoyl-L-serine
- N-oleoylethanolamine
- N-palmitoylethanolamine
- Na/Ca exchanger
- Nabilone
- Nabiximols
- NADPH oxidase
- NAGly
- Naloxone
- Narcotics
- National surveys
- natural compound
- natural killer cells
- natural products
- nausea
- negative estrogen feedback
- neonatal
- neonatal brain
- neonatal ischemia
- neonatal rat
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Neoplastic
- Nervous system
- Nervous system diseases
- NESARC
- Neural progenitor (NP)
- neural stem cells
- neurexin
- neuroblast
- Neuroblastoma
- neurodegeneration
- neurodegenerative disease/s
- neurodevelopment
- neurodevelopmental disorders
- Neurogenesis
- neuroimaging
- neuroimmunology
- neuroinflammation
- neuroligin
- neuromodulation
- Neuronal Plasticity
- Neurons
- neuropathic pain
- neuropathology
- neurophysiology
- neuroprotection
- neuroprotective effect
- Neuropsychiatric disorders
- neuropsychological impairment
- neuropsychological testing
- Neuropsychology
- neurorepair
- neurotoxicity
- neutral antagonism
- Newborn
- newborn animal
- NFL players
- night vision
- Nighttime agitation
- nitric oxide
- Nitroglycerin
- NMDA
- nocturnal arousal
- NOD mice
- nodose ganglia
- non-apoptotic cell death
- non-CB1/CB2
- non-opioid analgesics
- Non-psychoactive cannabinoids
- Non-psychotropic cannabinoid
- non-steroidal anti-inflammatory drug
- noradrenaline
- noradrenaline release
- norepinephrine
- NSAID
- O-1602
- O-2654
- obesity
- Observational
- Obsessive–compulsive disorder
- obstetrics
- obstructive lung disease
- OCCPI
- OF1 mice
- oil
- Oleoylethanolamide
- Oleoylethanolamine
- oligodendrocyte
- OMAR
- omega-3
- Omega-6
- omega-6 and omega-3 fatty acid ratio
- Omega-6 PUFA
- ontogeny
- opioid misuse
- opioid use
- opioid/s
- oral administration
- Oral Fluid
- oral morphine self-administration
- Org 27569
- Org 27759
- Org 29647
- orphan G-protein coupled receptor
- orphan receptor
- OSA
- Osteoarthritis
- osteoblast/s
- osteoclast/s
- osteoporosis
- osteosarcoma
- ouabain
- Ovalbumin
- Oxidation-Reduction
- oxidative stress
- P-glycoprotein (P-gp)
- paclitaxel
- pain
- pain management
- Palliative care
- palmitoylethanolamide.
- pancreatic cancer
- Parahippocampal Gyrus
- Parietal Lobe
- Parkinson’s disease
- Partial seizure
- parvalbumin
- Pattern Recognition
- PBMCs
- PC-3 cells
- Pediatric
- Pentylenetetrazole
- performance
- Perifusion
- perinatal asphyxia
- periventricular leukomalacia
- PET
- Petroleum Ether Extract
- Pharmacokinetics
- pharmacology
- pharmacotherapy
- PHEC-66
- Philadelphia chromosome
- phMRI
- Phoneutria nigriventer
- phospholipase
- Phosphoproteins antagonist
- Phytocannabinoid/s
- phytochemicals
- phytotherapy
- Pigs
- Pilocarpine-induced seizure
- pilot clinical study
- pinene
- pithed rabbit
- pituitary
- placebo-controlled
- Placenta
- Plant extracts
- plant natural products
- Plasma
- plasma adrenaline
- plasma cannabinoid concentration
- platelets
- play fighting
- PnTx4(6-1)
- polarization
- policy
- Polyacrylamide Gel
- Polymerase Chain Reaction
- polyphenols
- polyunsaturated fatty acids
- Polyvinylidendifluoride
- post-traumatic stress disorder (PTSD)
- posthypoxic state
- postnatal
- Postnatal exposure
- posttraumatic reaction-olfactory system
- PPAR
- PPARg
- PPARS a
- prebiotics
- preclinical
- Prefrontal cortex
- pregnancy
- prenatal
- preproenkephalin mRNA
- prescription drugs
- prescription pain pills
- pressurized aerosol
- presynaptic receptors
- prevalence
- prion
- Pro-Opiomelanocortin
- proliferation
- Promoter Regions
- Prospective study
- prostaglandin production
- prostaglandins
- Prostanoid
- prostate
- prostate cancer
- prostatic neoplasms
- Protein Binding
- Protein Kinase Inhibitors
- Protein Structure
- protein tyrosine phosphatases
- Proto-Oncogene Proteins c-akt/antagonists & inhibitors
- Psoriasis
- psychiatric comorbidity
- Psychiatric Status Rating Scales
- Psychiatry
- Psychosis
- psychosocial problems
- Psychostimulants
- Psychotropic Drugs
- puberty
- pulminary function
- purinergic
- putamen
- PVDF
- Pyridines
- qPCR
- QSAR
- quality of life
- quantitative PCR.
- R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin
- rabbit isolated adrenal gland
- radioligand binding assays
- randomized
- rapid eye movement sleep
- rapid eye movement sleep behaviour disorder
- Rat cerebral cortex
- rat mesenteric artery
- rat/s
- Reactive oxygen species
- receptor changes
- Receptor-dependent
- Receptor-independent
- Receptor/s
- reconsolidation blockade
- regional cerebral blood flow
- Regulatory
- rehabilitation
- relapse
- REM sleep
- remyelination
- RES13
- Resident–intruder paradigm
- restoration stroke
- retina
- retinitis pigmentosa
- retrograde neurotransmission
- retrograde signaling
- Rett Syndrome
- review
- Reward
- rhesus monkey
- Rheumatoid arthritis
- rhoA
- Rimonabant
- Risk
- RNA
- ROS
- rotarod
- RTT
- safety
- Satiety Response
- Sativex
- Sceletium tortuosum
- schizophrenia
- scrapie-infected mice
- sebocytes
- seizure
- self-administration
- self-efficacy
- semen quality
- sensorimotor gating
- Sensory nerves
- Sepsis
- septohippocampal pathway
- septum
- serotonin
- serum leptin level
- sex differences
- sex hormones
- Short-chain fatty acids
- shrew
- sickle cell disease
- side effects
- Signal
- Signal Transduction
- signaling
- signaling systems
- single-nucleotide polymorphism
- Skin cancer
- skin organ culture
- sleep
- Sleep-Induction
- sleep-waking cycle
- sleepiness
- slow wave sleep
- Smoking
- social anxiety
- social behavior
- Social interaction
- Social Stimulus
- sodium channels
- Somatostatin
- spasticity
- Spatial memory
- specialized proresolving mediators
- SPECT
- Sphingomyelin hydrolysis
- spider venom
- spinal cord
- Spinal cord injury
- spleen
- Spontaneously hypertensive rat (SHR)
- Sprague-Dawley
- SR 141716
- SR 141716A
- SR 147778
- SR141716
- SR141716A
- Staphylococcus aureus
- starvation
- Stat3 activation
- status epilepticus
- Stearoylethanolamine
- Steatosis
- stem/progenitor cell cultures
- Streptococcus pneumoniae Meningitis
- stress
- striatum
- stroke
- structural comparisons
- structural requirement
- Substance-Induced
- Substance-Related Disorders
- substantia nigra
- sulphasalazine
- survival
- survival signalling
- Sweat
- sympathetic nervous system
- sympathetic regulation
- symptom cluster
- Symptom dimension
- symptom management
- symptomatic therapy
- symptomatic treatment
- symptoms
- Synaptic plasticity
- Synaptic transmission
- synergistic effects
- synthetic cannabinoids
- synthetic CBD
- systematic review
- T cells
- Tail suspension test
- taste reactivity
- Tat
- tau
- TBC1D9
- Teens
- temozolomide
- Temporal lobe seizure
- teratology
- terpenes
- terpenoids
- Tertiary
- testicular function
- testis
- Testosterone
- THC/CBD spray
- Theiler’s virus
- Therapeutic potential
- Therapeutic uses
- therapeutics
- therapy
- thioacetamide
- thrombosis
- thromboxanes
- thymol
- tics
- Time Factors
- time lapse microscopy
- tissue inhibitor of matrix metalloproteinases-1
- TLRs
- TNF-α
- tobacco
- tolerability
- TOR Serine-Threonine Kinases antagonists
- Tourette syndrome
- toxicity
- toxin-induced vomiting
- trans-beta-ocimene
- transcaryophyllene
- Transcription
- transcription initiation sites
- Transducing antagonists
- transepithelial electrical resistance (TEER)
- transfection
- transient receptor potential vanilloid type 2
- transplant
- Traumatic brain injury (TBI)
- treatment
- treatment-resistant
- Trial of therapy
- TRIB3
- Trier Social Stress Test
- TRP channel
- trpv1
- tube formation
- Tumor
- Tumor cells
- tumor growth
- tumour xenograft models
- Type 2 diabetes
- U937 cells
- ulcerative colitis
- Ultra-high risk
- Uncoupling Protein 2
- United States
- URB597
- Urine
- Uterus
- Valproate
- Vanilloid receptor/s
- Vaping
- vascular biology
- vascular endothelial cells
- vascular endothelial growth factor receptor 3
- vasculature
- Vasodilation
- Vasorelaxation
- VCAM-1
- VDM-11
- Ventral Tegmental Area
- Veteran
- veterinary use
- viral G protein–coupled receptor
- Viral infections
- Virus
- visceral sensation
- vomiting
- wakefulness
- wasting disease
- weight loss
- well diffusion method
- white matter areas
- Whole Plant
- willardiine
- WIN 55-212-22
- WIN55212-2
- Wistar
- Wistar rat
- withdrawal
- working memory
- xenograft
- Xenopus laevis (Anura)
- Young Adult
- Zinc transporters
- zone of inhibition
- β-amyloid
- β-Caryophyllene
- δ-Ctenitoxin-Pn1a
- Δ8-Tetrahydrocannabinol